| 1 | ( L ) ASCORBATO DI CALCIO | - | - | - | - | [2] 96 96, 97 💬
|
| 2 | -aminosalicylic acid | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [2] 96 96, 97 💬
|
| 3 | 0,25 mg RPC1063 | - | - | - | - | [1] 96 96 💬
|
| 4 | 0.25 mg RPC1063 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 5 | 0.9% sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [5] 6 6, 14, 51, 53, 96 💬
|
| 6 | 00000 | - | - | - | - | [2] 6 6, 96 💬
|
| 7 | 0114-0006B | - | - | - | - | [2] 46 46, 96 💬
|
| 8 | 02458357 | - | - | - | - | [1] 96 96 💬
|
| 9 | 10 mg | - | - | - | - | [1] 96 96 💬
|
| 10 | 100% Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [6] 13 13, 15, 36, 96, 97, 269 💬
|
| 11 | 1000 IU D3 | - | - | - | - | [1] 96 96 💬
|
| 12 | 13-valent pneumococcal conjugated vaccine (PCV13) | - | - | - | - | [2] 96 96, 97 💬
|
| 13 | 1mg RPC1063 | - | - | - | - | [1] 96 96 💬
|
| 14 | 2'-Fucosyllactose | - | - | - | - | [2] 96 96, 97 💬
|
| 15 | 23-valent polysaccharide pneumococcal vaccine | - | - | - | - | [1] 96 96 💬
|
| 16 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | [2] 96 96, 97 💬
|
| 17 | 24mg bid TQH3906 capsule | - | - | - | - | [2] 96 96, 97 💬
|
| 18 | 25 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 💬
|
| 19 | 25mg adalimumab-680LT and 15/25 mg risankizumab-800CW | [2] Adalimumab Adalimumab, Risankizumab | [2] Adalimumab
Adalimumab
,
Risankizumab
💬
| [2] IL23A IL23A, TNF 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 20 | 3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III) | - | - | - | - | [2] 96 96, 97 💬
|
| 21 | 32mg TQH3906 capsule | - | - | - | - | [2] 96 96, 97 💬
|
| 22 | 331731-18-1 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 23 | 39560 | - | - | - | - | [2] 96 96, 97 💬
|
| 24 | 4-Aminosalicylic acid | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [1] 96 96 💬
|
| 25 | 4-Aminosalicylic acid extended release granules | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [1] 96 96 💬
|
| 26 | 40 mg | - | - | - | - | [1] 96 96 💬
|
| 27 | 40 mg MSB11022 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 28 | 42942019 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 29 | 5-aminolevulinic acid | [1] Aminolevulinic acid Aminolevulinic acid | [2] Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride
,
Aminolevulinic acid
💬
| - | - | [1] 96 96 💬
|
| 30 | 5-Aminosalicyl acid | - | - | - | - | [1] 96 96 💬
|
| 31 | 5-aminosalicylate (Pentasa, Ferring) | - | - | - | - | [2] 96 96, 97 💬
|
| 32 | 5-Aminosalicylic acid | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] Aminosalicylic acid
Aminosalicylic acid
,
Mesalamine
💬
| - | - | [2] 96 96, 97 💬
|
| 33 | 5-HTP | - | - | - | - | [2] 96 96, 97 💬
|
| 34 | 5000 IU D3 | - | - | - | - | [1] 96 96 💬
|
| 35 | 549-0261/F02-01 | - | - | - | - | [2] 96 96, 97 💬
|
| 36 | 6 Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 37 | 6-[(methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine | - | - | - | - | [1] 96 96 💬
|
| 38 | 6-Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [3] 96 96, 97, 164 💬
|
| 39 | 6-Mercaptopurine (Puri-Nethol) | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 96 96 💬
|
| 40 | 68125 | - | - | - | - | [2] 96 96, 97 💬
|
| 41 | 683699 | - | - | - | - | [1] 96 96 💬
|
| 42 | 75 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 💬
|
| 43 | 80 mg DR-6MP | - | - | - | - | [1] 96 96 💬
|
| 44 | 99mTc-S-HYNIC Certolizumab pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 💬
|
| 45 | ?-3 polyunsaturated fatty acid | - | - | - | - | [1] 96 96 💬
|
| 46 | [11C]AZ14132516 | - | - | - | - | [1] 96 96 💬
|
| 47 | [124I]IB PF 06687234 | - | - | - | - | [2] 96 96, 97 💬
|
| 48 | [14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 49 | [18F]FSPG | - | - | - | - | [2] 96 96, 97 💬
|
| 50 | [68Ga]Ga-DOTA-Cys-ATH001 | - | - | - | - | [1] 96 96 💬
|
| 51 | [ABBV-066] | - | - | - | - | [2] 96 96, 97 💬
|
| 52 | [ABBV-154] | - | - | - | - | [2] 46 46, 96 💬
|
| 53 | [ABT-494] | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 54 | [Adalimumab] | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 55 | [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | [2] 96 96, 97 💬
|
| 56 | [APD334] | - | - | - | - | [2] 96 96, 97 💬
|
| 57 | [BI 655130] | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 58 | [BI 706321] | - | - | - | - | [1] 96 96 💬
|
| 59 | [BMS-986165] | - | - | - | - | [2] 96 96, 97 💬
|
| 60 | [CNTO1275] | - | - | - | - | [2] 96 96, 97 💬
|
| 61 | [CNTO148] | - | - | - | - | [2] 96 96, 97 💬
|
| 62 | [CNTO1959] | - | - | - | - | [4] 37 37, 41, 96, 97 💬
|
| 63 | [CT-P13] | - | - | - | - | [2] 96 96, 97 💬
|
| 64 | [Cx601] | - | - | - | - | [1] 96 96 💬
|
| 65 | [GS-6034] | - | - | - | - | [2] 96 96, 97 💬
|
| 66 | [JNJ-64304500] | - | - | - | - | [1] 96 96 💬
|
| 67 | [JNJ-67864238] | - | - | - | - | [1] 96 96 💬
|
| 68 | [LY3074828] | - | - | - | - | [2] 96 96, 97 💬
|
| 69 | [MEDI2070] | - | - | - | - | [2] 96 96, 97 💬
|
| 70 | [MLN0002] | - | - | - | - | [1] 96 96 💬
|
| 71 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 72 | [OPS-2071] | - | - | - | - | [1] 96 96 💬
|
| 73 | [PF-06651600 50 mg] | - | - | - | - | [2] 96 96, 97 💬
|
| 74 | [PF-06700841 25 mg] | - | - | - | - | [2] 96 96, 97 💬
|
| 75 | [PF-06700841 5 mg] | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 76 | [RPC0163] | - | - | - | - | [1] 96 96 💬
|
| 77 | [RPC1063 equiv to ozanimod HCI] | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 78 | [RPC1063 equiv. to ozanimod HCI] | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 79 | [RPC1063] | - | - | - | - | [1] 96 96 💬
|
| 80 | [SHP647] | - | - | - | - | [2] 96 96, 97 💬
|
| 81 | [Stelara 130mg / 26mL concentrate for solution for | - | - | - | - | [1] 96 96 💬
|
| 82 | [Stelara 90mg/1ml solution for injecti | - | - | - | - | [1] 96 96 💬
|
| 83 | [TEV-48574] | - | - | - | - | [2] 96 96, 97 💬
|
| 84 | [Ustekinumab] | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 85 | [VTX958] | - | - | - | - | [1] 96 96 💬
|
| 86 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | [3] Clarithromycin Clarithromycin, Clofazimine, Rifabutin | [3] Clarithromycin
Clarithromycin
,
Clofazimine
,
Rifabutin
💬
| - | - | [1] 96 96 💬
|
| 87 | A-1293543.74 | - | - | - | - | [1] 96 96 💬
|
| 88 | AB1010 | - | - | - | - | [6] 2 2, 5, 6, 13, 46, 96 💬
|
| 89 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 90 | ABBV-066 | - | - | - | - | [2] 96 96, 97 💬
|
| 91 | ABBV-154 | - | - | - | - | [2] 46 46, 96 💬
|
| 92 | ABBV-8736 | - | - | - | - | [1] 96 96 💬
|
| 93 | ABR-215062 sodium salt | - | - | - | - | [2] 13 13, 96 💬
|
| 94 | Abrilumab | [1] Abrilumab Abrilumab | [1] Abrilumab
Abrilumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 95 | ABT 494 12mg | - | - | - | - | [2] 46 46, 96 💬
|
| 96 | ABT 494 3mg | - | - | - | - | [2] 46 46, 96 💬
|
| 97 | ABT Humira | - | - | - | - | [1] 96 96 💬
|
| 98 | ABT-494 | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 99 | ABT-874 | - | - | - | - | [1] 96 96 💬
|
| 100 | ABX464 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 101 | Accelerated 1 hour-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 102 | Accelerated 30 minutes-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 103 | ACDED + Modulen | - | - | - | - | [1] 96 96 💬
|
| 104 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 105 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 106 | Active comparator | - | - | - | - | [3] 6 6, 46, 96 💬
|
| 107 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
| 108 | Adalimumab (40 mg) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 109 | Adalimumab (D2E7) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 271 💬
|
| 110 | Adalimumab 40 mg eow or ew | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 111 | Adalimumab and Infliximab | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 112 | Adalimumab Dose Intensification | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 113 | Adalimumab Injection | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5] 38 38, 40, 46, 96, 162 💬
|
| 114 | Adalimumab PRN | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 115 | Adalimumab Solution for Injection | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 116 | Adalimumab-680LT | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 117 | Adalimumab-680LT 25mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 118 | Adipose derived allogenic mesenchymal stem cells (adAMSC) | - | - | - | - | [1] 96 96 💬
|
| 119 | AdMSC (CellReady®) | - | - | - | - | [1] 96 96 💬
|
| 120 | Adrenomedullin | [1] Adrenomedullin Adrenomedullin | - | - | - | [3] 96 96, 97, 124 💬
|
| 121 | ADSVF | - | - | - | - | [2] 15 15, 96 💬
|
| 122 | Adult human mesenchymal stem cells | - | - | - | - | [1] 96 96 💬
|
| 123 | Advancement plasty | - | - | - | - | [1] 96 96 💬
|
| 124 | Aero-red 100 mg/ml gotas orales en solución | - | - | - | - | [2] 96 96, 97 💬
|
| 125 | Afimkibart | [1] Afimkibart Afimkibart | [1] Afimkibart
Afimkibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [3] 46 46, 96, 97 💬
|
| 126 | After surgery for Crohn's disease, eligible patients will be randomized 1:1 to receive oral EXL01 | - | - | - | - | [1] 96 96 💬
|
| 127 | AGMB-129 | - | - | - | - | [1] 96 96 💬
|
| 128 | Agri-King Synbiotic (AKSB) | - | - | - | - | [1] 96 96 💬
|
| 129 | AIN457 | - | - | - | - | [9] 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
| 130 | Akkermansia muciniphila + Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 131 | Albendazole | [1] Albendazole Albendazole | [1] Albendazole
Albendazole
💬
| - | - | [1] 96 96 💬
|
| 132 | Albendazole (Eskazole) | [1] Albendazole Albendazole | [1] Albendazole
Albendazole
💬
| - | - | [1] 96 96 💬
|
| 133 | ALBUMINE HUMAINE | - | - | - | - | [1] 96 96 💬
|
| 134 | Aldesleukin | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 2 2, 49, 65, 96, 97 💬
|
| 135 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [21] 13 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
|
| 136 | Alequel | - | - | - | - | [2] 96 96, 97 💬
|
| 137 | Alfacalcidol | [1] Alfacalcidol Alfacalcidol | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 41 41, 46, 49, 50, 96, 107, 222, 223, 235, 238 💬
|
| 138 | Alicaforsen | [1] Alicaforsen Alicaforsen | [1] Alicaforsen sodium
Alicaforsen sodium
💬
| [1] ICAM1 ICAM1 💬
| [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Influenza A, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Staphylococcus aureus infection, TNF signaling pathway, Viral myocarditis 💬 | [2] 96 96, 97 💬
|
| 139 | Alicalm (polymeric liquid formula) | - | - | - | - | [1] 96 96 💬
|
| 140 | ALLO-ASC | - | - | - | - | [1] 96 96 💬
|
| 141 | ALLO-ASC-CD | - | - | - | - | [1] 96 96 💬
|
| 142 | ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED | - | - | - | - | [5] 36 36, 38, 53, 96, 162 💬
|
| 143 | Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs) | - | - | - | - | [1] 96 96 💬
|
| 144 | Allogeneic Bone Marrow Transplantation | - | - | - | - | [8] 60 60, 62, 65, 96, 164, 284, 285, 286 💬
|
| 145 | Allogeneic Stem Cell Therapy | - | - | - | - | [1] 96 96 💬
|
| 146 | Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601 | - | - | - | - | [1] 96 96 💬
|
| 147 | Allogenic eASCs 5 million cells/ml suspension for injection CX601 | - | - | - | - | [1] 96 96 💬
|
| 148 | Allogenic eASCs 5 million cells/ml suspension for injection. CX601 | - | - | - | - | [1] 96 96 💬
|
| 149 | Allogenic eASCs 5 million/ml suspension for injection. | - | - | - | - | [1] 96 96 💬
|
| 150 | Allogenic mesenchymal stem cell isolated from adipose tissue | - | - | - | - | [3] 38 38, 96, 162 💬
|
| 151 | Allopurinol | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [7] 6 6, 46, 57, 60, 66, 96, 97 💬
|
| 152 | Allopurinol Sandoz 100 mg, tabletten | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [1] 96 96 💬
|
| 153 | ALLOPURINOL SODIUM | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 154 | Alofisel | - | - | - | - | [1] 96 96 💬
|
| 155 | AlofiselProduct Name: Cx601Product Code: [Cx601]Pharmaceutical Form: Suspension for injectionINN or Proposed INN: DarvadstrocelCurrent Sponsor code: Allogenic eASCsOther descriptive name: Expanded human allogenic mesenchymal adult stem cells extracted from adiposetissue (eASCs)Concentration unit: OtherConcentration type: equalConcentration number: 5000000-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Intralesional use | - | - | - | - | [1] 96 96 💬
|
| 156 | Also referred to as 'MEDI2070' | - | - | - | - | [2] 96 96, 97 💬
|
| 157 | Also referred to as MED2070 | - | - | - | - | [1] 96 96 💬
|
| 158 | Also referred to as MEDI2070 | - | - | - | - | [2] 96 96, 97 💬
|
| 159 | ALX-0600 | - | - | - | - | [1] 96 96 💬
|
| 160 | AMG 139 | - | - | - | - | [1] 96 96 💬
|
| 161 | AMG 181 | - | - | - | - | [2] 96 96, 97 💬
|
| 162 | AMG 827 | - | - | - | - | [2] 46 46, 96 💬
|
| 163 | AMG 827 210 mg | - | - | - | - | [2] 46 46, 96 💬
|
| 164 | AMG 827 350 MG | - | - | - | - | [1] 96 96 💬
|
| 165 | AMG 827 700 MG | - | - | - | - | [1] 96 96 💬
|
| 166 | Amgevita | - | - | - | - | [2] 96 96, 97 💬
|
| 167 | AMGEVITA (Adalimumab biosimilar ) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 168 | Amgevita 40 mg Injektionslösung im Fertigpen | - | - | - | - | [2] 96 96, 97 💬
|
| 169 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | - | - | - | - | [2] 96 96, 97 💬
|
| 170 | Amgevita 40Mg Solution for Injection | - | - | - | - | [2] 96 96, 97 💬
|
| 171 | AMGEVITA® | - | - | - | - | [2] 96 96, 97 💬
|
| 172 | Aminolevulinic acid | [1] Aminolevulinic acid Aminolevulinic acid | [2] Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride
,
Aminolevulinic acid
💬
| - | - | [6] 34 34, 54, 96, 180, 254, 286 💬
|
| 173 | AMINOSALICYLIC ACID | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [2] 96 96, 97 💬
|
| 174 | Amitriptyline | [1] Amitriptyline Amitriptyline | [2] Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 96 96, 97, 226, 299 💬
|
| 175 | Ammonium chloride | [1] Ammonium chloride Ammonium chloride | [1] Ammonium chloride
Ammonium chloride
💬
| - | - | [3] 96 96, 107, 251 💬
|
| 176 | Amoxicillin | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [9] 6 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
|
| 177 | Amphotericin B | [1] Amphotericin B Amphotericin B | [1] Amphotericin B
Amphotericin B
💬
| - | - | [3] 96 96, 97, 299 💬
|
| 178 | AN100226 | - | - | - | - | [2] 13 13, 96 💬
|
| 179 | Andecaliximab | [1] Andecaliximab Andecaliximab | [1] Andecaliximab
Andecaliximab
💬
| [1] MMP9 MMP9 💬
| [16] Bladder cancer Bladder cancer, Diabetic cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Hepatitis B, IL-17 signaling pathway, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Pathways in cancer, Phagocytosis, Prostate cancer, Proteoglycans in cancer, Relaxin signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | [5] 46 46, 96, 97, 272, 299 💬
|
| 180 | AndoSan | - | - | - | - | [2] 96 96, 97 💬
|
| 181 | Anti TNF | - | - | - | - | [1] 96 96 💬
|
| 182 | Anti TNF Alfa. | - | - | - | - | [1] 96 96 💬
|
| 183 | Anti TNF humanized antibody Fab fragment-PEG conjugate | - | - | - | - | [1] 96 96 💬
|
| 184 | Anti TNF therapy including infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 185 | Anti-CD3 Monoclonal antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 186 | Anti-IL-12 | - | - | - | - | [2] 13 13, 96 💬
|
| 187 | Anti-IL-23 monoclonal antibody | - | - | - | - | [1] 96 96 💬
|
| 188 | Anti-IL-6 mAb | - | - | - | - | [2] 46 46, 96 💬
|
| 189 | Anti-IL12/23 or anti-IL23 - Risankizumab | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 190 | Anti-IL12/23 or anti-IL23 - Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 191 | Anti-inflammatory diet | - | - | - | - | [1] 96 96 💬
|
| 192 | Anti-integrin - Vedolizumab IV | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 193 | Anti-integrin - Vedolizumab IV and SC | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 194 | Anti-Interferon-gamma monoclonal antibody | - | - | - | - | [1] 96 96 💬
|
| 195 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2] 96 96, 97 💬
|
| 196 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 197 | Anti-Interleukin-6 Monoclonal Antibody | - | - | - | - | [2] 46 46, 96 💬
|
| 198 | Anti-MAdCAM antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 199 | Anti-Thymocyte Globulin (Rabbit) | [1] Rabbit Rabbit | - | - | - | [3] 60 60, 96, 285 💬
|
| 200 | Anti-TL1A monoclonal antibody, high dose | - | - | - | - | [2] 96 96, 97 💬
|
| 201 | Anti-TL1A monoclonal antibody, low dose | - | - | - | - | [2] 96 96, 97 💬
|
| 202 | Anti-TL1A monoclonal antibody, medium dose | - | - | - | - | [2] 96 96, 97 💬
|
| 203 | Anti-TNF | - | - | - | - | [4] 46 46, 96, 107, 271 💬
|
| 204 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | [2] 96 96, 97 💬
|
| 205 | Anti-TNF Drug | - | - | - | - | [2] 96 96, 97 💬
|
| 206 | Anti-TNF therapy | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 207 | Anti-TNF: Infliximab (Infusion) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 208 | Anti-TNF:Adalimumab (Subcutaneus) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 209 | Anti-tumour necrosis factor a antibodies | - | - | - | - | [1] 96 96 💬
|
| 210 | Antibiotics | - | - | - | - | [1] 96 96 💬
|
| 211 | Anticorpo monoclonale anti IL-23 | - | - | - | - | [1] 96 96 💬
|
| 212 | Anticorpo monoclonale anti-IL-23 | - | - | - | - | [1] 96 96 💬
|
| 213 | Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2) | - | - | - | - | [1] 96 96 💬
|
| 214 | Antithymocyte immunoglobulin (rabbit) | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 96 💬
|
| 215 | APD334 | - | - | - | - | [5] 93 93, 96, 97, 98, 269 💬
|
| 216 | APD371 | - | - | - | - | [1] 96 96 💬
|
| 217 | Apheresis catheter placement | - | - | - | - | [1] 96 96 💬
|
| 218 | Apixaban | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [6] 48 48, 96, 97, 222, 223, 279 💬
|
| 219 | Apixaban 2.5 milligram | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 96 96, 97 💬
|
| 220 | Application of Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 221 | AR401959 L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [3] 96 96, 97, 98 💬
|
| 222 | Arginine | [1] Arginine Arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [16] 2 2, 21, 46, 57, 58, 67, 72, 96, 97, 98, 113, 210, 223, 225, 251, 299 💬
|
| 223 | Artesunate | [1] Artesunate Artesunate | [1] Artesunate
Artesunate
💬
| - | - | [4] 18 18, 66, 86, 96 💬
|
| 224 | ASCs | - | - | - | - | [3] 53 53, 96, 97 💬
|
| 225 | ASCs: Adipose derived Stem Cells | - | - | - | - | [1] 96 96 💬
|
| 226 | Aspirin 81Mg Ec Tab | - | - | - | - | [2] 96 96, 97 💬
|
| 227 | AST-120 | - | - | - | - | [2] 96 96, 97 💬
|
| 228 | ATG | - | - | - | - | [6] 13 13, 19, 60, 96, 222, 285 💬
|
| 229 | ATH-063 | - | - | - | - | [2] 96 96, 97 💬
|
| 230 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [21] 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 231 | Autologous ADIpose derived stromal vascular fraction | - | - | - | - | [1] 96 96 💬
|
| 232 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | [1] 96 96 💬
|
| 233 | Autologous mesenchymal stromal cell | - | - | - | - | [2] 96 96, 298 💬
|
| 234 | Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population | - | - | - | - | [1] 96 96 💬
|
| 235 | Autologous stem cell transplant | - | - | - | - | [4] 28 28, 53, 56, 96 💬
|
| 236 | Autologous Stem Cell Transplantation | - | - | - | - | [4] 13 13, 28, 56, 96 💬
|
| 237 | Avaxim Pediatric® | - | - | - | - | [2] 96 96, 107 💬
|
| 238 | Avaxim ® (adult) | - | - | - | - | [2] 96 96, 107 💬
|
| 239 | AVB-114 | - | - | - | - | [1] 96 96 💬
|
| 240 | AVT02 (Alvotech Biosimilar to Adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 💬
|
| 241 | AZA | - | - | - | - | [4] 11 11, 40, 96, 97 💬
|
| 242 | AZA capsules | - | - | - | - | [1] 96 96 💬
|
| 243 | Azathioprin | - | - | - | - | [3] 46 46, 54, 96 💬
|
| 244 | Azathioprin-ratiopharm 25 mg | - | - | - | - | [1] 96 96 💬
|
| 245 | Azathioprin-ratiopharm 25mg Filmtabletten | - | - | - | - | [1] 96 96 💬
|
| 246 | Azathioprin-ratiopharm 50 mg Filmtabletten | - | - | - | - | [1] 96 96 💬
|
| 247 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 248 | Azathioprine (AZA) caps | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 249 | Azathioprine (AZA) or 6-mercaptopurine (6-MP) | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 250 | Azathioprine + infliximab | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 251 | Azathioprine - ratiopharm 50 mg | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 252 | Azathioprine / 6 Mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 96 96 💬
|
| 253 | Azathioprine in case of endoscopic recurrence | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 254 | Azathioprine individualised dose | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 255 | Azathioprine or 6-mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 256 | Azathioprine or adalimumab and infliximab | [3] Adalimumab Adalimumab, Azathioprine, Infliximab | [4] Azathioprine
Azathioprine
,
Adalimumab
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 257 | Azathioprine OR Mesalazine | [2] Azathioprine Azathioprine, Mesalazine | [3] Azathioprine
Azathioprine
,
Mesalamine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 258 | AZATHIOPRINE or METHOTREXATE | [2] Azathioprine Azathioprine, Methotrexate | [4] Methotrexate
Methotrexate
,
Azathioprine
,
Methotrexate sodium
,
Azathioprine sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 96 96 💬
|
| 259 | Azathioprine weight-based dose | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 260 | Azathioprine+enteral nutrition | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 261 | Azatioprina | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [2] 96 96, 97 💬
|
| 262 | AZATIOPRINA ASPEN - 50 COMPRESSE | - | - | - | - | [1] 96 96 💬
|
| 263 | AZD7798 | - | - | - | - | [1] 96 96 💬
|
| 264 | AZD9056 | - | - | - | - | [2] 46 46, 96 💬
|
| 265 | Azithromycin | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [8] 13 13, 84, 85, 96, 222, 228, 299, 340 💬
|
| 266 | Azithromycin + Metronidazole | [2] Azithromycin Azithromycin, Metronidazole | [5] Metronidazole
Metronidazole
,
Azithromycin hydrate
,
Metronidazole hydrochloride
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 96 96 💬
|
| 267 | Azithromycin Pill | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 96 96 💬
|
| 268 | B. theta | - | - | - | - | [1] 96 96 💬
|
| 269 | Bacillus Subtilis | [1] Bacillus subtilis Bacillus subtilis | - | - | - | [3] 6 6, 28, 96 💬
|
| 270 | Bacillus subtilis Capsules | [1] Bacillus subtilis Bacillus subtilis | - | - | - | [1] 96 96 💬
|
| 271 | Bacteriophage preparation | - | - | - | - | [1] 96 96 💬
|
| 272 | Bacteriotherapy | - | - | - | - | [2] 96 96, 97 💬
|
| 273 | Bacteroides thetaiotaomicron | [1] Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron | - | - | - | [1] 96 96 💬
|
| 274 | Balinatunfib | [1] Balinatunfib Balinatunfib | [1] Balinatunfib
Balinatunfib
💬
| [2] TNFRSF1A TNFRSF1A, TNFRSF1B 💬
| [35] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, NF-kappa B signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TNF signaling pathway, Toxoplasmosis, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 275 | BDHK-2009 Tablets | - | - | - | - | [2] 96 96, 97 💬
|
| 276 | Bean | [1] Bean Bean | - | - | - | [1] 96 96 💬
|
| 277 | Behavioral: AbbVie Care 2.0 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 278 | Behavioral: exclusion diet | - | - | - | - | [1] 96 96 💬
|
| 279 | Behavioral: Hypnosis | - | - | - | - | [1] 96 96 💬
|
| 280 | Behavioral: Mediterranean diet | - | - | - | - | [2] 96 96, 97 💬
|
| 281 | Beta carotene | [1] Beta carotene Beta carotene | [1] beta Carotene
beta Carotene
💬
| - | - | [1] 96 96 💬
|
| 282 | Beta carotene from Dunaliella algae | [1] Beta carotene Beta carotene | [1] beta Carotene
beta Carotene
💬
| - | - | [1] 96 96 💬
|
| 283 | Betamethasone | [1] Betamethasone Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 2 2, 28, 46, 56, 65, 83, 90, 96, 235 💬
|
| 284 | Bezlotoxumab | [1] Bezlotoxumab Bezlotoxumab | [1] Bezlotoxumab
Bezlotoxumab
💬
| - | - | [2] 96 96, 97 💬
|
| 285 | BI 655066 | - | - | - | - | [2] 96 96, 271 💬
|
| 286 | BI 655066 10 mg/ml | - | - | - | - | [1] 96 96 💬
|
| 287 | BI 655066 90 mg/ml | - | - | - | - | [2] 96 96, 271 💬
|
| 288 | BI 655130 | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 289 | BI 695501 | - | - | - | - | [2] 46 46, 96 💬
|
| 290 | BI 706321 | - | - | - | - | [1] 96 96 💬
|
| 291 | Bi-PegLyte | - | - | - | - | [2] 96 96, 97 💬
|
| 292 | BI706321 | - | - | - | - | [1] 96 96 💬
|
| 293 | BIA | [1] BIA BIA | - | - | - | [4] 6 6, 86, 96, 299 💬
|
| 294 | BIBR 796 BS, 20 mg | - | - | - | - | [1] 96 96 💬
|
| 295 | BIBR 796 BS, 5 mg | - | - | - | - | [1] 96 96 💬
|
| 296 | Bif195 capsules | - | - | - | - | [1] 96 96 💬
|
| 297 | Bifidobacterium infantis 35624 | - | - | - | - | [2] 96 96, 97 💬
|
| 298 | Biologic Agent | - | - | - | - | [2] 96 96, 97 💬
|
| 299 | Biological agents | - | - | - | - | [2] 46 46, 96 💬
|
| 300 | Biological Drug | - | - | - | - | [4] 46 46, 96, 97, 107 💬
|
| 301 | Biological samplings | - | - | - | - | [1] 96 96 💬
|
| 302 | Biologics | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 303 | Biosimilar | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 304 | Biosimilar Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 305 | Biospecimen Collection | - | - | - | - | [18] 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 306 | Bleomycin | [1] Bleomycin Bleomycin | [3] Bleomycin sulfate
Bleomycin sulfate
,
Bleomycin hydrochloride
,
Bleomycin
💬
| - | - | [4] 96 96, 278, 279, 280 💬
|
| 307 | BLI-1300 high dose | - | - | - | - | [1] 96 96 💬
|
| 308 | BLI-1300 low dose | - | - | - | - | [1] 96 96 💬
|
| 309 | Blood and fecal samples | - | - | - | - | [2] 96 96, 97 💬
|
| 310 | Blood and stools samples | - | - | - | - | [1] 96 96 💬
|
| 311 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 312 | Blood samples | - | - | - | - | [14] 13 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
|
| 313 | Blood sampling | - | - | - | - | [15] 2 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
|
| 314 | Blood sampling from infant | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 315 | Blood sampling from mother | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 316 | Blood sampling from umbilical cord | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 317 | Blood test | - | - | - | - | [19] 2 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
|
| 318 | Blue light photopheresis | - | - | - | - | [1] 96 96 💬
|
| 319 | Blueberry | [1] Blueberry Blueberry | - | - | - | [2] 96 96, 97 💬
|
| 320 | Blueberry-rich diet | [1] Blueberry Blueberry | - | - | - | [2] 96 96, 97 💬
|
| 321 | BMS-188667 | - | - | - | - | [10] 46 46, 49, 53, 65, 96, 97, 107, 222, 223, 271 💬
|
| 322 | BMS-936557 | - | - | - | - | [2] 96 96, 97 💬
|
| 323 | BMS-936557 (Anti-IP-10 Antibody) | - | - | - | - | [1] 96 96 💬
|
| 324 | BMS-945429 | [1] Clazakizumab Clazakizumab | [1] Clazakizumab
Clazakizumab
💬
| - | - | [2] 46 46, 96 💬
|
| 325 | BMS-986165 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 326 | BMS986165 | - | - | - | - | [2] 96 96, 97 💬
|
| 327 | Bone Marrow Derived Mesenchymal Stem cells (MSCs) | - | - | - | - | [1] 96 96 💬
|
| 328 | Boulardii | - | - | - | - | [2] 96 96, 97 💬
|
| 329 | BRAZIKUMAB | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 330 | Brazikumab high dose | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 331 | Brazikumab Induction Dose | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 332 | Brazikumab IV Infusion | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 333 | Brazikumab low dose | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 334 | Brazikumab Maintenance Dose | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 335 | Brazikumab SC Injection | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 336 | Breast Milk Sample Collection | - | - | - | - | [1] 96 96 💬
|
| 337 | Breast milk sampling | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 338 | Brepocitinib | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5] 49 49, 50, 84, 96, 97 💬
|
| 339 | Brepocitinib 25 mg | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 96 96, 97 💬
|
| 340 | Brepocitinib 5 mg | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 96 96, 97 💬
|
| 341 | Brepocitinib 5mg | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 96 96 💬
|
| 342 | BT-11 | - | - | - | - | [2] 96 96, 97 💬
|
| 343 | BT-11 1000mg | - | - | - | - | [2] 96 96, 97 💬
|
| 344 | BT-11 500 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 345 | BT-11 880 mg | - | - | - | - | [1] 96 96 💬
|
| 346 | Budenofalk | - | - | - | - | [1] 96 96 💬
|
| 347 | Budenofalk 3mg gastro-resistant capsules | - | - | - | - | [1] 96 96 💬
|
| 348 | Budenofalk 9mg gastro-resistant granules | - | - | - | - | [1] 96 96 💬
|
| 349 | BUDESONIDE | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10] 66 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
|
| 350 | Budezonide | - | - | - | - | [1] 96 96 💬
|
| 351 | Bupivacaine | [1] Bupivacaine Bupivacaine | [2] Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [10] 46 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬
|
| 352 | Bupivacaine/epinephrine/dexamethasone | [3] Bupivacaine Bupivacaine, Dexamethasone, Epinephrine | [8] Epinephrine
Epinephrine
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Epinephrine hydrochloride
,
Bupivacaine hydrochloride
,
Epinephrine bitartrate
,
Bupivacaine
,
Dexamethasone phosphate
💬
| [16] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 💬
|
| 353 | Bupropion | [1] Bupropion Bupropion | [3] Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [7] 8 8, 18, 21, 96, 97, 171, 298 💬
|
| 354 | By demand | - | - | - | - | [2] 96 96, 97 💬
|
| 355 | C326 | [1] C326 C326 | - | - | - | [1] 96 96 💬
|
| 356 | C326, IL-6 Inhibitory Avimer protein | [1] C326 C326 | - | - | - | [1] 96 96 💬
|
| 357 | Cabozantinib | [1] Cabozantinib Cabozantinib | [2] Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| [3] AXL AXL, KDR, MET 💬
| [28] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [9] 13 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
|
| 358 | Caffeine | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
| 359 | Caffeine 100 mg | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 360 | Calcitonin nasal spray (salmon) | - | - | - | - | [2] 96 96, 97 💬
|
| 361 | Calcitriol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [11] 18 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
|
| 362 | Calcium | [1] Calcium Calcium | - | - | - | [39] 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 363 | Calcium carbonate | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [10] 13 13, 19, 46, 53, 71, 75, 96, 97, 235, 299 💬
|
| 364 | Caltrate Pill | - | - | - | - | [1] 96 96 💬
|
| 365 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [20] 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
| 366 | Cannabidiol , synthetic form | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 96 96 💬
|
| 367 | Cannabis, Medical | - | - | - | - | [5] 2 2, 6, 13, 96, 97 💬
|
| 368 | Capsule endoscopy | - | - | - | - | [1] 96 96 💬
|
| 369 | Capsule fecal microbiota material (cap-FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 96 96 💬
|
| 370 | CC-5013 | - | - | - | - | [2] 28 28, 96 💬
|
| 371 | CCX282-B | - | - | - | - | [1] 96 96 💬
|
| 372 | CD-C-Food | - | - | - | - | [1] 96 96 💬
|
| 373 | CD7 CAR T-cells | - | - | - | - | [3] 50 50, 96, 97 💬
|
| 374 | CDED+dairy | - | - | - | - | [1] 96 96 💬
|
| 375 | CDED+PEN | - | - | - | - | [1] 96 96 💬
|
| 376 | CDP6038 | - | - | - | - | [2] 46 46, 96 💬
|
| 377 | CDP870 | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 378 | Cefiderocol | [1] Cefiderocol Cefiderocol | [2] Cefiderocol sulfate tosylate
Cefiderocol sulfate tosylate
,
Cefiderocol
💬
| - | - | [3] 96 96, 97, 299 💬
|
| 379 | Cefmetazole | [1] Cefmetazole Cefmetazole | [2] Cefmetazole
Cefmetazole
,
Cefmetazole sodium
💬
| - | - | [2] 96 96, 97 💬
|
| 380 | CELEBREX | - | - | - | - | [4] 46 46, 96, 107, 271 💬
|
| 381 | CELECOXIB | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [14] 2 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
| 382 | Certican | - | - | - | - | [3] 67 67, 96, 228 💬
|
| 383 | Certolizumab | - | - | - | - | [6] 46 46, 48, 49, 96, 270, 271 💬
|
| 384 | Certolizumab Pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [10] 37 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
|
| 385 | Certolizumab pegol (CDP870) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 💬
|
| 386 | Certolizumab pegol (CDP870, CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 387 | Certolizumab Pegol (CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 107, 271 💬
|
| 388 | Certolizumab pegol (rINN) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 389 | Certolizumab Pegol /Cimzia | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 390 | Certolizumab pegol 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 391 | ChAdOx2 HAV | - | - | - | - | [1] 96 96 💬
|
| 392 | Chenodeoxycholic acid | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [5] 20 20, 86, 96, 234, 263 💬
|
| 393 | Chenodiol | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 96 96 💬
|
| 394 | Chenofalk | - | - | - | - | [1] 96 96 💬
|
| 395 | Chimeric IgG1 monoclonal antibody | - | - | - | - | [1] 96 96 💬
|
| 396 | CHLORURE DE SODIUM | - | - | - | - | [1] 96 96 💬
|
| 397 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 13 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
|
| 398 | Cholecalciferol 10,000 IU | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 399 | Cholecalciferol 400 IU | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 400 | CHOLECALCIFEROL CONCENTRATE | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 401 | CHOLECALCIFEROL CONCENTRATE (WATER-DISPERSIBLE FORM) | [2] Cholecalciferol Cholecalciferol, Water | [2] Water
Water
,
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 402 | Cholestagel | - | - | - | - | [2] 79 79, 96 💬
|
| 403 | Chondroitin sulfate | [1] Chondroitin sulfate Chondroitin sulfate | [1] Chondroitin sulfate A
Chondroitin sulfate A
💬
| - | - | [2] 96 96, 226 💬
|
| 404 | CIMZIA | - | - | - | - | [7] 46 46, 48, 49, 96, 97, 107, 271 💬
|
| 405 | Cimzia 200 mg solution for injection | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 406 | Ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [6] 2 2, 46, 60, 96, 97, 299 💬
|
| 407 | Ciprofloxacin hydrochloride | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [2] 96 96, 299 💬
|
| 408 | Clarithromycin | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬
| - | - | [10] 6 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
|
| 409 | CliniMACS® TCR a/beta Reagent Kit and CliniMACS® CD19 System | - | - | - | - | [3] 19 19, 96, 222 💬
|
| 410 | CliniMACS® TCR a/ß Reagent Kit and CliniMACS® CD19 System | - | - | - | - | [3] 19 19, 96, 222 💬
|
| 411 | Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬
| [3] POLA1 POLA1, POLA2, RRM1 💬
| [5] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [9] 19 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
|
| 412 | CLOFAZIMINE | [1] Clofazimine Clofazimine | [1] Clofazimine
Clofazimine
💬
| - | - | [2] 96 96, 299 💬
|
| 413 | CNTO 1275 | - | - | - | - | [2] 13 13, 96 💬
|
| 414 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 💬
|
| 415 | CNTO148 | - | - | - | - | [5] 46 46, 84, 96, 97, 107 💬
|
| 416 | CNTO1959 | - | - | - | - | [4] 37 37, 41, 96, 97 💬
|
| 417 | COLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [4] 13 13, 46, 96, 228 💬
|
| 418 | Colecalciferol D3 (Vigantol Oil) | - | - | - | - | [2] 96 96, 97 💬
|
| 419 | Colesevelam | [1] Colesevelam Colesevelam | [2] Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | [3] 79 79, 96, 260 💬
|
| 420 | Colonoscopic fecal microbiota material (colo-FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 96 96 💬
|
| 421 | Colonoscopy | - | - | - | - | [2] 96 96, 97 💬
|
| 422 | Colony-purified Bacteroides thetaiotaomicron (B.theta) | [1] Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron | - | - | - | [1] 96 96 💬
|
| 423 | ColoVit capsule | - | - | - | - | [1] 96 96 💬
|
| 424 | Combination Product: CDED (Crohn's Disease Exclusion Diet) in addition to anti-TNF therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 425 | Combination Product: Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration of unlabeled vedolizumab | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 426 | Companion diagnostic (CDx) | - | - | - | - | [1] 96 96 💬
|
| 427 | Comparator | - | - | - | - | [1] 96 96 💬
|
| 428 | Computed Tomography | - | - | - | - | [13] 26 26, 28, 34, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
| 429 | Confocal laser endomicroscopy | - | - | - | - | [1] 96 96 💬
|
| 430 | Continuous Mononuclear Cell Collection (CMNC) | - | - | - | - | [1] 96 96 💬
|
| 431 | Contrast Enhanced Ultrasound | - | - | - | - | [1] 96 96 💬
|
| 432 | Contrast Media, Magnetic Resonance | - | - | - | - | [2] 94 94, 96 💬
|
| 433 | Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [2] 96 96, 97 💬
|
| 434 | Coolonic biopsies | - | - | - | - | [2] 96 96, 97 💬
|
| 435 | CoQ10 | - | - | - | - | [4] 5 5, 6, 8, 96 💬
|
| 436 | Cortecosteroid | - | - | - | - | [1] 96 96 💬
|
| 437 | Corticosteroid | - | - | - | - | [12] 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
|
| 438 | CosmoFer | - | - | - | - | [2] 96 96, 97 💬
|
| 439 | CosmoFer 50mg/ml solution for infusion or injection | - | - | - | - | [2] 96 96, 97 💬
|
| 440 | CP-461 | - | - | - | - | [1] 96 96 💬
|
| 441 | CP-690,550 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 442 | CP-690,550-10 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 443 | CPSI-2364 | - | - | - | - | [1] 96 96 💬
|
| 444 | Cranberry | [1] Cranberry Cranberry | - | - | - | [2] 13 13, 96 💬
|
| 445 | Cranberry powder | [1] Cranberry Cranberry | - | - | - | [1] 96 96 💬
|
| 446 | Creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [9] 2 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
|
| 447 | Crohn's Disease | - | - | - | - | [1] 96 96 💬
|
| 448 | Crohn's disease exclusion diet | - | - | - | - | [1] 96 96 💬
|
| 449 | Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 💬
|
| 450 | Crohns Disease Exclusion Diet + PEN | - | - | - | - | [1] 96 96 💬
|
| 451 | CROWN | - | - | - | - | [1] 96 96 💬
|
| 452 | CT-P13 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 453 | CT-P13 SC (Infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 454 | CTLA4Ig | - | - | - | - | [5] 46 46, 49, 96, 223, 271 💬
|
| 455 | Curcuma | - | - | - | - | [1] 96 96 💬
|
| 456 | CURCUMA LONGA RHIZOMA | - | - | - | - | [1] 96 96 💬
|
| 457 | Curcumin | [1] Curcumin Curcumin | - | - | - | [12] 2 2, 13, 34, 36, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
| 458 | Cx401 | - | - | - | - | [1] 96 96 💬
|
| 459 | Cx601 | - | - | - | - | [1] 96 96 💬
|
| 460 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 461 | CYCLOPHOSPHAMIDE MONOHYDRATE | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [4] 13 13, 60, 96, 256 💬
|
| 462 | Cyltezo | - | - | - | - | [1] 96 96 💬
|
| 463 | Cytochrome P450 (CYP) Substrates | - | - | - | - | [2] 96 96, 97 💬
|
| 464 | Cytoxan | - | - | - | - | [2] 60 60, 96 💬
|
| 465 | D-CURA | - | - | - | - | [1] 96 96 💬
|
| 466 | D3 VitaCaps® | - | - | - | - | [2] 96 96, 97 💬
|
| 467 | D9421-C | - | - | - | - | [1] 96 96 💬
|
| 468 | D9421-C capsule 3 mg | - | - | - | - | [1] 96 96 💬
|
| 469 | D9421-C, 15mg | - | - | - | - | [1] 96 96 💬
|
| 470 | D9421-C, 9mg | - | - | - | - | [1] 96 96 💬
|
| 471 | DARVADSTROCEL | [1] Darvadstrocel Darvadstrocel | [1] Darvadstrocel
Darvadstrocel
💬
| - | - | [1] 96 96 💬
|
| 472 | DB adalimumab 40 mg eow | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 473 | DB adalimumab 40 mg ew | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 474 | DB-3Q | - | - | - | - | [1] 96 96 💬
|
| 475 | Decortin 20 mg | - | - | - | - | [1] 96 96 💬
|
| 476 | Decortin 5 mg | - | - | - | - | [1] 96 96 💬
|
| 477 | Dehydroepiandrosterone [DHEA] | - | - | - | - | [1] 96 96 💬
|
| 478 | Dekristol 20.000 ie | - | - | - | - | [1] 96 96 💬
|
| 479 | Delayed Release 6 mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 96 96 💬
|
| 480 | Delayed Release 6MP or Calcitriol vs. Purinethol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 481 | Denosumab | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [11] 46 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬
|
| 482 | Deucravacitinib | [1] Deucravacitinib Deucravacitinib | [1] Deucravacitinib
Deucravacitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [10] 36 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
|
| 483 | DEXA scan | - | - | - | - | [3] 19 19, 46, 96 💬
|
| 484 | Dexametasone sodium phosphate | - | - | - | - | [2] 96 96, 97 💬
|
| 485 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 486 | Dexamethasone (IV) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 96 96, 97 💬
|
| 487 | DEXAMETHASONE SODIUM PHOSPHATE | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 65 65, 70, 96 💬
|
| 488 | Dexamethasone sodium phosphate 250 mg/ 10 ml | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 489 | Dextran | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [5] 2 2, 62, 79, 96, 97 💬
|
| 490 | Dextromethorphan | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [10] 2 2, 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
|
| 491 | Dextromethorphan 30 mg | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 96 96, 97 💬
|
| 492 | Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT | - | - | - | - | [1] 96 96 💬
|
| 493 | Diagnostic Test: Baseline blood sample | - | - | - | - | [1] 96 96 💬
|
| 494 | Diagnostic Test: Baseline intestinal biopsies | - | - | - | - | [1] 96 96 💬
|
| 495 | Diagnostic Test: Baseline stool sample | - | - | - | - | [1] 96 96 💬
|
| 496 | Diagnostic Test: Blood | - | - | - | - | [1] 96 96 💬
|
| 497 | Diagnostic Test: blood biomarkers | - | - | - | - | [1] 96 96 💬
|
| 498 | Diagnostic Test: Blood draw | - | - | - | - | [8] 34 34, 65, 85, 86, 96, 97, 240, 299 💬
|
| 499 | Diagnostic Test: Coronal T1 weighted spin echo images | - | - | - | - | [2] 96 96, 97 💬
|
| 500 | Diagnostic Test: Imaging | - | - | - | - | [3] 51 51, 94, 96 💬
|
| 501 | Diagnostic Test: interferon gamma releasing assay (IGRA) | [1] Interferon Gamma Interferon Gamma | - | - | - | [1] 96 96 💬
|
| 502 | Diagnostic Test: Leucine-rich a2-glycoprotein | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [2] 96 96, 97 💬
|
| 503 | Diagnostic Test: Magnetic resonance spectroscopy | - | - | - | - | [3] 96 96, 97, 299 💬
|
| 504 | Diagnostic Test: MRI imaging | - | - | - | - | [1] 96 96 💬
|
| 505 | Diagnostic Test: Post treatment blood sample | - | - | - | - | [1] 96 96 💬
|
| 506 | Diagnostic Test: Post treatment intestinal biopsies | - | - | - | - | [1] 96 96 💬
|
| 507 | Diagnostic Test: Post treatment stool sample | - | - | - | - | [1] 96 96 💬
|
| 508 | Diagnostic Test: Saliva | - | - | - | - | [1] 96 96 💬
|
| 509 | Diagnostic Test: serum leucine-rich alpha-2 glycoprotein (LRG) levels | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [2] 96 96, 97 💬
|
| 510 | Diagnostic Test: Spin-lattice relaxation (T1) | - | - | - | - | [2] 96 96, 97 💬
|
| 511 | Diagnostic Test: Stool | - | - | - | - | [2] 96 96, 97 💬
|
| 512 | Diagnostic Test: stool biomarkers | - | - | - | - | [1] 96 96 💬
|
| 513 | Diet 1 | - | - | - | - | [2] 96 96, 97 💬
|
| 514 | Diet 2 | - | - | - | - | [2] 96 96, 97 💬
|
| 515 | Dietary therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 516 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon | [1] Ammonium chloride Ammonium chloride | [1] Ammonium chloride
Ammonium chloride
💬
| - | - | [1] 96 96 💬
|
| 517 | Dietician designed diet | - | - | - | - | [1] 96 96 💬
|
| 518 | Diflucan | [1] Fluconazole Fluconazole | [1] Fluconazole
Fluconazole
💬
| - | - | [1] 96 96 💬
|
| 519 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [12] 11 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
|
| 520 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] Dipyridamole
Dipyridamole
💬
| [2] PDE4A PDE4A, PDE5A 💬
| [5] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 46 46, 49, 51, 66, 96, 222, 224 💬
|
| 521 | DLX105 | - | - | - | - | [1] 96 96 💬
|
| 522 | Doxycycline | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [17] 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
|
| 523 | DOXYCYCLINE HYCLATE | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [3] 23 23, 96, 227 💬
|
| 524 | Duvakitug | [1] Duvakitug Duvakitug | [1] Duvakitug
Duvakitug
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 525 | E-Device | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 526 | E6011 | - | - | - | - | [4] 46 46, 93, 96, 97 💬
|
| 527 | E6011 10 mg/kg | - | - | - | - | [1] 96 96 💬
|
| 528 | E6011 15 mg/kg | - | - | - | - | [1] 96 96 💬
|
| 529 | E6011 2 mg/kg | - | - | - | - | [1] 96 96 💬
|
| 530 | E6011 5 mg/kg | - | - | - | - | [1] 96 96 💬
|
| 531 | Early biologic therapy | - | - | - | - | [1] 96 96 💬
|
| 532 | Early faecal calprotectin dosage | - | - | - | - | [1] 96 96 💬
|
| 533 | Early immunosuppressants (azathioprine, methotrexate) | [2] Azathioprine Azathioprine, Methotrexate | [4] Methotrexate
Methotrexate
,
Azathioprine
,
Methotrexate sodium
,
Azathioprine sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 96 96 💬
|
| 534 | EB8018 | - | - | - | - | [1] 96 96 💬
|
| 535 | EB8018 (First-in-class FimH blocker) | - | - | - | - | [1] 96 96 💬
|
| 536 | Ebetrex | - | - | - | - | [2] 96 96, 97 💬
|
| 537 | Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml | - | - | - | - | [2] 96 96, 97 💬
|
| 538 | EBFAHF-2 | - | - | - | - | [1] 96 96 💬
|
| 539 | EEN | - | - | - | - | [1] 96 96 💬
|
| 540 | EEN (Nestle Modulen®) | - | - | - | - | [1] 96 96 💬
|
| 541 | EEN intervention group | - | - | - | - | [1] 96 96 💬
|
| 542 | EFALIZUMAB | [1] Efalizumab Efalizumab | [1] Efalizumab
Efalizumab
💬
| [1] ITGAL ITGAL 💬
| [14] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [10] 11 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬
|
| 543 | Efmarodocokin alfa | [1] Efmarodocokin alfa Efmarodocokin alfa | [1] Efmarodocokin alfa
Efmarodocokin alfa
💬
| [1] IL22 IL22 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 544 | Egg | [1] Egg Egg | - | - | - | [2] 96 96, 310 💬
|
| 545 | Egg Albumen Powder | [2] Egg Egg, Egg white | - | - | - | [1] 96 96 💬
|
| 546 | Egg white | [2] Egg Egg, Egg white | - | - | - | [1] 96 96 💬
|
| 547 | EGG WHITE PROTEIN | [2] Egg Egg, Egg white | - | - | - | [1] 96 96 💬
|
| 548 | Eicosapentaenoic acid | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 549 | EMEA/H/C/000240 | - | - | - | - | [2] 96 96, 97 💬
|
| 550 | EMEA/H/C/002576 | - | - | - | - | [2] 96 96, 97 💬
|
| 551 | EMEA/H/C/002778 | - | - | - | - | [1] 96 96 💬
|
| 552 | Empagliflozin | [1] Empagliflozin Empagliflozin | [1] Empagliflozin
Empagliflozin
💬
| - | - | [17] 28 28, 46, 57, 58, 65, 67, 72, 77, 86, 96, 97, 113, 222, 223, 257, 298, 299 💬
|
| 553 | Endopath from Itamar medical - FDA approved device. | - | - | - | - | [1] 96 96 💬
|
| 554 | Endoscopic balloon dilatation | - | - | - | - | [1] 96 96 💬
|
| 555 | ENDOXAN BAXTER | - | - | - | - | [3] 13 13, 43, 96 💬
|
| 556 | Entecavir | [1] Entecavir Entecavir | [2] Entecavir
Entecavir
,
Entecavir
💬
| - | - | [8] 46 46, 56, 96, 97, 107, 222, 223, 271 💬
|
| 557 | Enteral nutrition | - | - | - | - | [1] 96 96 💬
|
| 558 | Enteral nutrition biscuits | - | - | - | - | [1] 96 96 💬
|
| 559 | Enteral nutrition. | - | - | - | - | [1] 96 96 💬
|
| 560 | Enteral nutritional suspension | - | - | - | - | [1] 96 96 💬
|
| 561 | Entocort | - | - | - | - | [1] 96 96 💬
|
| 562 | Entocort CR | - | - | - | - | [2] 96 96, 97 💬
|
| 563 | Entocort® Kapseln | - | - | - | - | [1] 96 96 💬
|
| 564 | Entyvio | - | - | - | - | [3] 94 94, 96, 97 💬
|
| 565 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 566 | Epanova | - | - | - | - | [1] 96 96 💬
|
| 567 | Epanova™ (Omega-3 Free Fatty Acids) | - | - | - | - | [1] 96 96 💬
|
| 568 | Epaxal Berna (virosomal hepatitis A vaccine) | [1] Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [2] 96 96, 97 💬
|
| 569 | Epinephrine | [1] Epinephrine Epinephrine | [3] Epinephrine
Epinephrine
,
Epinephrine hydrochloride
,
Epinephrine bitartrate
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 46 46, 70, 96, 97 💬
|
| 570 | ERB-041 | - | - | - | - | [3] 46 46, 96, 226 💬
|
| 571 | Ergocalciferol | [1] Ergocalciferol Ergocalciferol | [1] Ergocalciferol
Ergocalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5] 46 46, 84, 96, 97, 299 💬
|
| 572 | ERY-DEX | - | - | - | - | [1] 96 96 💬
|
| 573 | ERYTHROPOIETIN | [1] Erythropoietin Erythropoietin | [4] Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [11] 2 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
|
| 574 | ESKETAMINE | [1] Esketamine Esketamine | [2] Esketamine
Esketamine
,
Esketamine hydrochloride
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [7] 2 2, 4, 6, 70, 96, 97, 156 💬
|
| 575 | Etiprednol dicloacetate | [1] Etiprednol dicloacetate Etiprednol dicloacetate | [1] Etiprednol dicloacetate
Etiprednol dicloacetate
💬
| - | - | [1] 96 96 💬
|
| 576 | Etrasimod | [1] Etrasimod Etrasimod | [2] Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 96 96, 97, 98 💬
|
| 577 | Etrasimod L-arginine | [3] Arginine Arginine, Etrasimod, L-arginine | [5] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
,
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 96 96, 97, 98 💬
|
| 578 | ETROLIZUMAB | [1] Etrolizumab Etrolizumab | [1] Etrolizumab
Etrolizumab
💬
| [1] ITGB7 ITGB7 💬
| [13] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Integrin signaling, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | [2] 96 96, 97 💬
|
| 579 | EU/1/03/268/002 | - | - | - | - | [1] 96 96 💬
|
| 580 | EU/1/99/116/003 | - | - | - | - | [1] 96 96 💬
|
| 581 | EUA with seton placement if necessary | - | - | - | - | [1] 96 96 💬
|
| 582 | EUS | - | - | - | - | [1] 96 96 💬
|
| 583 | Everolimus | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [12] 34 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
|
| 584 | Exclusion diet | - | - | - | - | [1] 96 96 💬
|
| 585 | Exclusive Enteral Nutrition | - | - | - | - | [1] 96 96 💬
|
| 586 | Exclusive Enteral Nutrition Therapy | - | - | - | - | [1] 96 96 💬
|
| 587 | Exclusive enteral nutrition treatment group | - | - | - | - | [1] 96 96 💬
|
| 588 | EXL01 | - | - | - | - | [1] 96 96 💬
|
| 589 | ExoFlo | - | - | - | - | [2] 96 96, 97 💬
|
| 590 | Expanded allogenic adipose-derived adult stem cells | - | - | - | - | [1] 96 96 💬
|
| 591 | Expanded autologous adipose-derived adult stem cells (eASCs) | - | - | - | - | [1] 96 96 💬
|
| 592 | Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eASCs) | - | - | - | - | [1] 96 96 💬
|
| 593 | Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eASCs) | - | - | - | - | [1] 96 96 💬
|
| 594 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue | - | - | - | - | [1] 96 96 💬
|
| 595 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs | - | - | - | - | [1] 96 96 💬
|
| 596 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs) | - | - | - | - | [1] 96 96 💬
|
| 597 | Extracorporeal Photopheresis | - | - | - | - | [3] 13 13, 46, 96 💬
|
| 598 | Faecal microbiota transplantation | - | - | - | - | [5] 46 46, 84, 96, 97, 271 💬
|
| 599 | Fat stem cell | - | - | - | - | [1] 96 96 💬
|
| 600 | FE 999301 | - | - | - | - | [2] 96 96, 97 💬
|
| 601 | Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's | - | - | - | - | [2] 96 96, 97 💬
|
| 602 | Fecal Microbial transplant | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 603 | Fecal microbial transplantation | - | - | - | - | [3] 6 6, 96, 97 💬
|
| 604 | Fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [14] 2 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
|
| 605 | Fecal Microbiota Transplant | [1] Fecal microbiota Fecal microbiota | - | - | - | [2] 96 96, 97 💬
|
| 606 | Fecal Microbiota Transplant (FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [2] 96 96, 97 💬
|
| 607 | Fecal microbiota transplantation | [1] Fecal microbiota Fecal microbiota | - | - | - | [9] 2 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
|
| 608 | Fecal microbiota transplantation (FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [4] 94 94, 96, 97, 222 💬
|
| 609 | Ferric Carboxy Maltose | [1] Maltose Maltose | [1] Maltose
Maltose
💬
| - | - | [2] 96 96, 97 💬
|
| 610 | FERRIC CARBOXYMALTOSE | [1] Ferric carboxymaltose Ferric carboxymaltose | [1] Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | [4] 86 86, 96, 97, 299 💬
|
| 611 | Ferric Maltol | [1] Ferric maltol Ferric maltol | [1] Ferric maltol
Ferric maltol
💬
| - | - | [2] 96 96, 97 💬
|
| 612 | Ferrous sulphate | - | - | - | - | [2] 96 96, 97 💬
|
| 613 | FFP104 | - | - | - | - | [2] 93 93, 96 💬
|
| 614 | Fibrin | [1] Fibrin Fibrin | - | - | - | [3] 96 96, 97, 279 💬
|
| 615 | Fibrin glue injection in fistula | [1] Fibrin Fibrin | - | - | - | [1] 96 96 💬
|
| 616 | FILGOTINIB | [1] Filgotinib Filgotinib | [2] Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [10] 46 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
|
| 617 | Filgrastim | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [30] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 618 | Fish Oil | [1] Fish oil Fish oil | - | - | - | [10] 13 13, 46, 49, 50, 66, 79, 96, 260, 294, 299 💬
|
| 619 | FITC-Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 620 | Flagyl | - | - | - | - | [2] 96 96, 97 💬
|
| 621 | Flixabi | - | - | - | - | [2] 96 96, 97 💬
|
| 622 | Fluconazole | [1] Fluconazole Fluconazole | [1] Fluconazole
Fluconazole
💬
| - | - | [3] 67 67, 96, 225 💬
|
| 623 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 624 | Fludarabine phosphate | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [14] 28 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
|
| 625 | Fluorescence molecular imaging procedure using vedolizumab-800CW | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 626 | Fluoropyrimidine | - | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 627 | FMT | - | - | - | - | [3] 96 96, 97, 271 💬
|
| 628 | Folacin | - | - | - | - | [2] 96 96, 97 💬
|
| 629 | FolateScan (Technetium Tc 99mEC20) | - | - | - | - | [4] 13 13, 46, 49, 96 💬
|
| 630 | Foralumab | [1] Foralumab Foralumab | - | - | - | [3] 13 13, 17, 96 💬
|
| 631 | Formula | - | - | - | - | [1] 96 96 💬
|
| 632 | FOS | - | - | - | - | [2] 66 66, 96 💬
|
| 633 | Fosfato sodico de dexametasona | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 634 | Fosfomycin | [1] Fosfomycin Fosfomycin | [3] Fosfomycin tromethamine
Fosfomycin tromethamine
,
Fosfomycin sodium
,
Fosfomycin
💬
| - | - | [2] 96 96, 97 💬
|
| 635 | Freeze dried grape powder | [1] Grape Grape | - | - | - | [2] 96 96, 97 💬
|
| 636 | Fully human IgG1 monoclonal antibody specific for TL1A | - | - | - | - | [2] 96 96, 97 💬
|
| 637 | Fully humanised, recombinant monoclonal antibody (IgG1) | - | - | - | - | [1] 96 96 💬
|
| 638 | G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [12] 6 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
|
| 639 | G321605 | - | - | - | - | [3] 85 85, 96, 97 💬
|
| 640 | Ga68-FAPI-46 | - | - | - | - | [1] 96 96 💬
|
| 641 | GED-0301 | - | - | - | - | [2] 96 96, 97 💬
|
| 642 | Genetic: Blood or saliva sample collection | - | - | - | - | [3] 96 96, 97, 299 💬
|
| 643 | Genetic: genetic analysis | - | - | - | - | [8] 34 34, 85, 90, 93, 94, 96, 234, 265 💬
|
| 644 | Genetic: Genome-wide DNA methylation | - | - | - | - | [1] 96 96 💬
|
| 645 | Genetic: HLADQA1*05A>G screening | - | - | - | - | [2] 96 96, 97 💬
|
| 646 | Genetic: PGx-guided post-operative pain management | - | - | - | - | [2] 96 96, 97 💬
|
| 647 | Genetic: TPMT genotyping | - | - | - | - | [2] 96 96, 97 💬
|
| 648 | Glatiramer | [1] Glatiramer Glatiramer | [1] Glatiramer acetate
Glatiramer acetate
💬
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [4] 2 2, 13, 96, 156 💬
|
| 649 | GLATIRAMER ACETATE | [2] Acetate Acetate, Glatiramer | [1] Glatiramer acetate
Glatiramer acetate
💬
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [3] 13 13, 96, 156 💬
|
| 650 | Gliolan | - | - | - | - | [1] 96 96 💬
|
| 651 | GLPG0634 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 652 | GLPG1205 | - | - | - | - | [3] 85 85, 96, 97 💬
|
| 653 | Glucagon | [1] Glucagon Glucagon | [2] Glucagon
Glucagon
,
Glucagon hydrochloride
💬
| [1] GCGR GCGR 💬
| [3] Glucagon signaling pathway Glucagon signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 654 | Glucocorticoids | - | - | - | - | [13] 35 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
|
| 655 | Glutamine | [1] L-Glutamine L-Glutamine | [1] Glutamine
Glutamine
💬
| - | - | [7] 87 87, 89, 96, 97, 113, 245, 299 💬
|
| 656 | Glycan | - | - | - | - | [1] 96 96 💬
|
| 657 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 658 | GOLIMUMAB | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 46 46, 56, 84, 96, 97, 107, 270, 271 💬
|
| 659 | Grape | [1] Grape Grape | - | - | - | [2] 96 96, 97 💬
|
| 660 | Group 2 ustekinumab 130 mg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 661 | Group 3: ustekinumab approximately 6 mg/kg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 662 | Group A | - | - | - | - | [1] 96 96 💬
|
| 663 | Group B | - | - | - | - | [1] 96 96 💬
|
| 664 | Growth Hormone | - | - | - | - | [10] 19 19, 46, 78, 96, 97, 107, 191, 193, 265, 299 💬
|
| 665 | GS-5745 | [1] GS-5745 GS-5745 | - | - | - | [4] 46 46, 96, 97, 299 💬
|
| 666 | GS-6034 | - | - | - | - | [4] 46 46, 53, 96, 97 💬
|
| 667 | GSK1070806 | - | - | - | - | [2] 56 56, 96 💬
|
| 668 | GSK1605786 | - | - | - | - | [2] 96 96, 97 💬
|
| 669 | GSK1605786 500 mg | - | - | - | - | [1] 96 96 💬
|
| 670 | GSK1605786 capsule | - | - | - | - | [1] 96 96 💬
|
| 671 | GSK1605786 ChemoCentryx: formulation A | - | - | - | - | [1] 96 96 💬
|
| 672 | GSK1605786 GSK direct-fill: formulation C | - | - | - | - | [1] 96 96 💬
|
| 673 | GSK1605786 GSK modified-process: formulation D | - | - | - | - | [1] 96 96 💬
|
| 674 | GSK1605786 GSK tablet: formulation E | - | - | - | - | [1] 96 96 💬
|
| 675 | GSK1605786 GSK: formulation B | - | - | - | - | [1] 96 96 💬
|
| 676 | GSK1605786A | - | - | - | - | [2] 96 96, 97 💬
|
| 677 | GSK2330811 | - | - | - | - | [2] 51 51, 96 💬
|
| 678 | GUSELKUMAB | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [7] 37 37, 41, 51, 96, 97, 161, 269 💬
|
| 679 | Guselkumab (GUS) | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 680 | Guselkumab (Tremfya) | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 681 | Guselkumab Dose 1 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 💬
|
| 682 | Guselkumab Dose 2 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 💬
|
| 683 | Guselkumab Dose 3 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 684 | Guselkumab Dose 4 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 685 | Guselkumab Dose 5 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 686 | Guselkumab Subcutaneous | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 687 | GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 96 96 💬
|
| 688 | HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells | - | - | - | - | [2] 17 17, 96 💬
|
| 689 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 690 | Hepatitis A Vaccine | [1] Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [3] 46 46, 96, 97 💬
|
| 691 | Herpes Zoster Vaccine | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 692 | Hextend | - | - | - | - | [2] 96 96, 97 💬
|
| 693 | High dose TSO | - | - | - | - | [1] 96 96 💬
|
| 694 | High Oligosaccharide Group | - | - | - | - | [1] 96 96 💬
|
| 695 | High serine diet | [1] Serine Serine | [1] Serine
Serine
💬
| - | - | [1] 96 96 💬
|
| 696 | High-dose Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 96 96 💬
|
| 697 | HM201 | - | - | - | - | [2] 96 96, 97 💬
|
| 698 | HMB | - | - | - | - | [1] 96 96 💬
|
| 699 | HMPL-004 | - | - | - | - | [2] 96 96, 97 💬
|
| 700 | HMPL004-6599 | - | - | - | - | [2] 96 96, 97 💬
|
| 701 | Hulio | - | - | - | - | [2] 96 96, 97 💬
|
| 702 | HuM291 | - | - | - | - | [2] 96 96, 97 💬
|
| 703 | HUMAN ALBUMIN AS MACROAGGREGATES | - | - | - | - | [1] 96 96 💬
|
| 704 | Human Anti-IL-12 Antibody | - | - | - | - | [1] 96 96 💬
|
| 705 | Human anti-IP10 monoclonal antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 706 | Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40 | - | - | - | - | [1] 96 96 💬
|
| 707 | Human Placenta-Derived Cells PDA001 Intravenous Infusion | - | - | - | - | [1] 96 96 💬
|
| 708 | HUMAN PLASMA FOR FRACTIONATION | - | - | - | - | [1] 96 96 💬
|
| 709 | Human TH-SC01 cell injection | - | - | - | - | [1] 96 96 💬
|
| 710 | Human Umbilical Cord Mesenchymal Stem Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [5] 13 13, 96, 97, 113, 271 💬
|
| 711 | HUMIRA | - | - | - | - | [9] 46 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
|
| 712 | Humira (adalimumab original) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 713 | HUMIRA (ADALIMUMAB) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 💬
|
| 714 | HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL | - | - | - | - | [2] 46 46, 96 💬
|
| 715 | Humira 20 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 96 96 💬
|
| 716 | Humira 40 mg injekcní roztok v predplnené injekcní stríkacce | - | - | - | - | [1] 96 96 💬
|
| 717 | HUMIRA 40 mg solución inyectable en jeringa precargada | - | - | - | - | [2] 46 46, 96 💬
|
| 718 | Humira 40 mg solution for injection in pre-filled pen | - | - | - | - | [1] 96 96 💬
|
| 719 | Humira 40 mg solution for injection in pre-filled syringe | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 720 | Humira 40 mg/0.8 ml solution for injection | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 721 | HUMIRA 40Mg Solution for Injection | - | - | - | - | [2] 96 96, 97 💬
|
| 722 | Humira 40mg/0.4ml pre-filled syringe | - | - | - | - | [2] 96 96, 97 💬
|
| 723 | Humira 40mg/0.8ml solution for injection for paediatric use | - | - | - | - | [1] 96 96 💬
|
| 724 | Humira pre-filled PEN | - | - | - | - | [1] 96 96 💬
|
| 725 | HUMIRA ® | - | - | - | - | [2] 96 96, 97 💬
|
| 726 | HUMIRA*SC 2SIR+F 40MG 0,8ML+2T | - | - | - | - | [2] 46 46, 96 💬
|
| 727 | Humira® | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 728 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [29] 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 729 | HYDROXYCHLOROQUINE SULPHATE | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [1] 96 96 💬
|
| 730 | Hyperbaric oxygen treatment (HBOT) | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [6] 13 13, 15, 36, 96, 97, 269 💬
|
| 731 | IBD-AID diet combined with Kate Farms Peptide 1.5 | - | - | - | - | [1] 96 96 💬
|
| 732 | Ibuprofen | [1] Ibuprofen Ibuprofen | [5] Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [8] 13 13, 46, 65, 96, 107, 113, 271, 299 💬
|
| 733 | ICG-guided bowel perfusion assessment | - | - | - | - | [1] 96 96 💬
|
| 734 | Icotrokinra | [1] Icotrokinra Icotrokinra | [1] Icotrokinra
Icotrokinra
💬
| [1] IL23R IL23R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 735 | IGG2 ANTIBODIES | - | - | - | - | [2] 96 96, 97 💬
|
| 736 | IL-23 inhibitor | - | - | - | - | [1] 96 96 💬
|
| 737 | IL-23 Therapy | - | - | - | - | [1] 96 96 💬
|
| 738 | Ileocecal resection | - | - | - | - | [1] 96 96 💬
|
| 739 | Ileocolonic biopsies | - | - | - | - | [1] 96 96 💬
|
| 740 | Ileocolonoscopy | - | - | - | - | [1] 96 96 💬
|
| 741 | IM90838 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 742 | Immune Ablation and Hematopoietic Stem Cell Support | - | - | - | - | [1] 96 96 💬
|
| 743 | Immunonutrition | - | - | - | - | [2] 96 96, 226 💬
|
| 744 | Immunosuppressant | - | - | - | - | [2] 96 96, 224 💬
|
| 745 | IMMUNOSUPPRESSIVE AGENTS | - | - | - | - | [4] 13 13, 50, 96, 223 💬
|
| 746 | Immunosuppressor/TNFalpha | - | - | - | - | [1] 96 96 💬
|
| 747 | Immunotherapy | - | - | - | - | [1] 96 96 💬
|
| 748 | IMP will be labeled as ''PF-04236921 106mg/vial, Clonal SC lyophilized form''. | - | - | - | - | [1] 96 96 💬
|
| 749 | IMP will be labeled as PF-04236921 106mg/vial, Clonal SC lyophilized form | - | - | - | - | [1] 96 96 💬
|
| 750 | Imraldi | - | - | - | - | [2] 96 96, 97 💬
|
| 751 | IMU-838 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 752 | Imuran | - | - | - | - | [2] 96 96, 97 💬
|
| 753 | IMUREL | - | - | - | - | [7] 13 13, 44, 45, 46, 54, 96, 97 💬
|
| 754 | IMUREL 25 mg | - | - | - | - | [3] 44 44, 45, 96 💬
|
| 755 | Increlex | - | - | - | - | [2] 65 65, 96 💬
|
| 756 | Increlex 10mg/ml solution for injection | - | - | - | - | [1] 96 96 💬
|
| 757 | Indocyanine green | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [9] 22 22, 41, 46, 51, 96, 235, 278, 291, 296 💬
|
| 758 | Inflectra | - | - | - | - | [4] 46 46, 56, 96, 97 💬
|
| 759 | Inflectra 100 mg powder for concentrate for solution for infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 760 | Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
|
| 761 | Infliximab (IFX alone) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 762 | Infliximab (Remicade) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 271 💬
|
| 763 | Infliximab (Remicade): 100 mg of lyophilized infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 764 | Infliximab 10 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 765 | Infliximab 20 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 766 | Infliximab 5 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 767 | Infliximab 5 mg/kg body weight infused over 2 hours | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 768 | Infliximab 5 mg/kg every 6 weeks | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 769 | Infliximab 7 mg/kg every 8 weeks | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 770 | Infliximab [infliximab biosimilar 3] | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 37 37, 46, 96, 97 💬
|
| 771 | Infliximab and adalimumab | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 772 | Infliximab and azathioprine combination at week 0 | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 773 | Infliximab and azathioprine combination at week 14 | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 774 | Infliximab and immunosuppressives | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 775 | Infliximab combined with azathioprine therapy | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 776 | Infliximab Dose Intensification | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 777 | Infliximab infusion | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 778 | Infliximab monotherapy | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 779 | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib | [6] Adalimumab Adalimumab, Golimumab, Infliximab, Tofacitinib, Ustekinumab, Vedolizumab | [7] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
,
Tofacitinib citrate
,
Tofacitinib
💬
| [10] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TNF, TYK2 💬
| [97] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 780 | Infliximab precision dosing | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 781 | Infliximab subcutaneous | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 782 | Infliximab therapeutic drug monitoring | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 783 | Infliximab with azathioprine (IIFX + AZA) | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 784 | Infliximab+azathioprine | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 785 | Infliximab, adalimumab, certolizumab pegol | [3] Adalimumab Adalimumab, Certolizumab pegol, Infliximab | [3] Adalimumab
Adalimumab
,
Infliximab
,
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 786 | Infliximab, azathioprine | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 787 | Infliximab-Biosimilar | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 788 | Infliximab-Dyyb | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 789 | Infliximab-Innovator | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 790 | Injection of CNK-UT009 | - | - | - | - | [2] 96 96, 97 💬
|
| 791 | Injection of iron | - | - | - | - | [1] 96 96 💬
|
| 792 | Injection of thawed SVF | - | - | - | - | [1] 96 96 💬
|
| 793 | Innovator infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 794 | Inositol | [1] Inositol Inositol | [1] Inositol
Inositol
💬
| - | - | [3] 96 96, 97, 118 💬
|
| 795 | Instillation of fibrin glue | [1] Fibrin Fibrin | - | - | - | [1] 96 96 💬
|
| 796 | Interferon alfa | [1] Interferon alfa Interferon alfa | [1] Interferon alfa
Interferon alfa
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [5] 25 25, 26, 28, 56, 96 💬
|
| 797 | INTERFERON BETA-1A | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [2] Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [5] 13 13, 14, 26, 96, 97 💬
|
| 798 | Interferon Gamma | [1] Interferon Gamma Interferon Gamma | - | - | - | [9] 18 18, 65, 85, 96, 107, 228, 299, 301, 326 💬
|
| 799 | Interleukin 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
|
| 800 | Interleukin 23 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 801 | Interleukin-2 (aldesleukin). | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 96 96, 97 💬
|
| 802 | Intestinal biopsies | - | - | - | - | [2] 96 96, 97 💬
|
| 803 | Intestinal resection | - | - | - | - | [1] 96 96 💬
|
| 804 | Intestinal surgery for Crohn's Disease | - | - | - | - | [1] 96 96 💬
|
| 805 | Intestinal ultrasound | - | - | - | - | [1] 96 96 💬
|
| 806 | Intralipid | - | - | - | - | [1] 96 96 💬
|
| 807 | Intralipid 10% | - | - | - | - | [1] 96 96 💬
|
| 808 | Intralipid 20% | - | - | - | - | [1] 96 96 💬
|
| 809 | Intrinsically labelled protein | - | - | - | - | [1] 96 96 💬
|
| 810 | Inulin | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [5] 6 6, 96, 97, 156, 299 💬
|
| 811 | Inulin/Inulin C13 | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [2] 96 96, 97 💬
|
| 812 | Investigational Product | - | - | - | - | [1] 96 96 💬
|
| 813 | InVita D3 | - | - | - | - | [1] 96 96 💬
|
| 814 | Iodine | [1] Iodine Iodine | [1] Iodine
Iodine
💬
| - | - | [5] 28 28, 46, 88, 96, 118 💬
|
| 815 | Ipilimumab | [1] Ipilimumab Ipilimumab | [1] Ipilimumab
Ipilimumab
💬
| [1] CTLA4 CTLA4 💬
| [4] Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | [9] 13 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
|
| 816 | Iron | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [7] 18 18, 60, 96, 97, 238, 254, 284 💬
|
| 817 | Iron sucrose | [3] Iron Iron, Iron sucrose, Sucrose | [3] Sucrose
Sucrose
,
Ferrous fumarate
,
Iron sucrose
💬
| - | - | [3] 62 62, 96, 97 💬
|
| 818 | Iron sulphate | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 819 | Iron sulphate 200mg coated tablets | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 820 | Iron supplement 300-600 mg/day | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 821 | Iron(III)- hydroxide dextran complex | [2] Dextran Dextran, Iron | [6] Dextran 1
Dextran 1
,
Ferrous fumarate
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 822 | Isoflavone | [1] Isoflavone Isoflavone | - | - | - | [2] 96 96, 97 💬
|
| 823 | ITF 2357 | - | - | - | - | [1] 96 96 💬
|
| 824 | ITF2357 | - | - | - | - | [4] 96 96, 107, 113, 267 💬
|
| 825 | Itraconazole | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬
| - | - | [13] 2 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
|
| 826 | Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally. | [2] Itraconazole Itraconazole, Terbinafine | [3] Itraconazole
Itraconazole
,
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | [1] 96 96 💬
|
| 827 | IV Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 828 | J695 | - | - | - | - | [1] 96 96 💬
|
| 829 | J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0 | - | - | - | - | [1] 96 96 💬
|
| 830 | JNJ-40346527-AAC | - | - | - | - | [1] 96 96 💬
|
| 831 | JNJ-64304500 | - | - | - | - | [1] 96 96 💬
|
| 832 | JNJ-64304500-AAA | - | - | - | - | [1] 96 96 💬
|
| 833 | JNJ-67864238 | - | - | - | - | [1] 96 96 💬
|
| 834 | JNJ-78934804 | - | - | - | - | [2] 96 96, 97 💬
|
| 835 | Kanamycin | [1] Kanamycin Kanamycin | [2] Kanamycin sulfate
Kanamycin sulfate
,
Kanamycin sulfate
💬
| - | - | [2] 96 96, 291 💬
|
| 836 | KENACORT | - | - | - | - | [2] 90 90, 96 💬
|
| 837 | KleanLyte | - | - | - | - | [2] 96 96, 97 💬
|
| 838 | Kremezin | - | - | - | - | [2] 96 96, 97 💬
|
| 839 | Kremezin®, Spherical Adsorptive Carbon | - | - | - | - | [2] 96 96, 97 💬
|
| 840 | L 44 | - | - | - | - | [1] 96 96 💬
|
| 841 | L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [10] 2 2, 21, 46, 67, 96, 97, 98, 113, 223, 299 💬
|
| 842 | L-Carnitine | - | - | - | - | [5] 13 13, 46, 86, 96, 240 💬
|
| 843 | L01BA | - | - | - | - | [1] 96 96 💬
|
| 844 | L04AB04 | - | - | - | - | [5] 46 46, 96, 107, 160, 271 💬
|
| 845 | L04AX01 | - | - | - | - | [1] 96 96 💬
|
| 846 | L2-01 adipose-derived mesenchymal stem cells (MSC) | - | - | - | - | [1] 96 96 💬
|
| 847 | Lactated Ringers | - | - | - | - | [2] 96 96, 97 💬
|
| 848 | Lactobacillus salivarius UCC118 | - | - | - | - | [2] 96 96, 97 💬
|
| 849 | Lactulose | [1] Lactulose Lactulose | [1] Lactulose
Lactulose
💬
| - | - | [5] 6 6, 13, 96, 97, 291 💬
|
| 850 | Lactulose/Rhamnose solution | [2] Lactulose Lactulose, Rhamnose | [1] Lactulose
Lactulose
💬
| - | - | [1] 96 96 💬
|
| 851 | Lap TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] Epinephrine
Epinephrine
,
Epinephrine hydrochloride
,
Bupivacaine hydrochloride
,
Epinephrine bitartrate
,
Bupivacaine
💬
| [15] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 852 | LAQUINIMOD | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [4] 8 8, 13, 49, 96 💬
|
| 853 | Laquinimod capsules 0.5 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [2] 8 8, 96 💬
|
| 854 | Laquinimod Cápsulas 0.5 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 96 96 💬
|
| 855 | Late biologic therapy | - | - | - | - | [1] 96 96 💬
|
| 856 | Laxabon | - | - | - | - | [1] 96 96 💬
|
| 857 | LDP-02 | - | - | - | - | [2] 96 96, 97 💬
|
| 858 | Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [13] 5 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
|
| 859 | Leukapheresis | - | - | - | - | [6] 49 49, 51, 85, 96, 284, 285 💬
|
| 860 | LH VIOLA Supplementation | - | - | - | - | [2] 96 96, 97 💬
|
| 861 | Lipitor | - | - | - | - | [4] 51 51, 79, 96, 299 💬
|
| 862 | Liposomal bupivacaine | [1] Bupivacaine Bupivacaine | [2] Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [3] 51 51, 70, 96 💬
|
| 863 | LMT503 | - | - | - | - | [2] 96 96, 97 💬
|
| 864 | LO4AB02 | - | - | - | - | [1] 96 96 💬
|
| 865 | Losartan | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [20] 17 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
|
| 866 | Low dose naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 867 | Low dose TSO | - | - | - | - | [1] 96 96 💬
|
| 868 | Low fiber diet | - | - | - | - | [1] 96 96 💬
|
| 869 | Low serine diet | [1] Serine Serine | [1] Serine
Serine
💬
| - | - | [1] 96 96 💬
|
| 870 | Low-dose IL-2 administration | - | - | - | - | [1] 96 96 💬
|
| 871 | Lumbar puncture | - | - | - | - | [9] 2 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
|
| 872 | Lumentin 44 | - | - | - | - | [1] 96 96 💬
|
| 873 | Lutikizumab | [1] Lutikizumab Lutikizumab | [1] Lutikizumab
Lutikizumab
💬
| [2] IL1A IL1A, IL1B 💬
| [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [3] 46 46, 96, 97 💬
|
| 874 | LY3074828 | - | - | - | - | [2] 96 96, 97 💬
|
| 875 | LY4395089 | - | - | - | - | [2] 96 96, 97 💬
|
| 876 | Lymphocyte immune globulin | - | - | - | - | [1] 96 96 💬
|
| 877 | Magnetic Resonance Enterography (MRE) | - | - | - | - | [1] 96 96 💬
|
| 878 | Maltodextrin | [1] Maltodextrin Maltodextrin | [1] Maltodextrin
Maltodextrin
💬
| - | - | [4] 6 6, 13, 96, 97 💬
|
| 879 | Maltose | [1] Maltose Maltose | [1] Maltose
Maltose
💬
| - | - | [2] 96 96, 97 💬
|
| 880 | Mango | [1] Mango Mango | - | - | - | [2] 96 96, 97 💬
|
| 881 | Mango polyphenolics | [1] Mango Mango | - | - | - | [2] 96 96, 97 💬
|
| 882 | Mannitol | [1] Mannitol Mannitol | [1] Mannitol
Mannitol
💬
| - | - | [8] 6 6, 13, 21, 28, 60, 96, 113, 299 💬
|
| 883 | Mare´s milk | - | - | - | - | [2] 96 96, 97 💬
|
| 884 | MASITINIB | [1] Masitinib Masitinib | [1] Masitinib
Masitinib
💬
| [1] KIT KIT 💬
| [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [6] 2 2, 5, 6, 13, 46, 96 💬
|
| 885 | MASITINIB MESYLATE | [1] Masitinib Masitinib | [1] Masitinib
Masitinib
💬
| [1] KIT KIT 💬
| [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [6] 2 2, 5, 6, 13, 46, 96 💬
|
| 886 | MB-102 | - | - | - | - | [1] 96 96 💬
|
| 887 | MBF-118 oral capsules | - | - | - | - | [1] 96 96 💬
|
| 888 | MDGN-002 | - | - | - | - | [1] 96 96 💬
|
| 889 | MDX-1100 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 890 | Measurement of serum infliximab and anti-infliximab antibodies | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 891 | Mecasermin | [1] Mecasermin Mecasermin | [2] Mecasermin
Mecasermin
,
Mecasermin rinfabate
💬
| [2] GHR GHR, IGF1R 💬
| [34] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cadherin signaling, Cytokine-cytokine receptor interaction, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, Integrin signaling, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [4] 96 96, 168, 265, 299 💬
|
| 892 | Mecasermin [rDNA Origin] 10mg/ml solution | [1] Mecasermin Mecasermin | [2] Mecasermin
Mecasermin
,
Mecasermin rinfabate
💬
| [2] GHR GHR, IGF1R 💬
| [34] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cadherin signaling, Cytokine-cytokine receptor interaction, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, Integrin signaling, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 893 | MEDI2070 | - | - | - | - | [2] 96 96, 97 💬
|
| 894 | Medical Cannabis | [1] Medical Cannabis Medical Cannabis | [1] Cannabis
Cannabis
💬
| - | - | [3] 6 6, 96, 97 💬
|
| 895 | Mediterranean Crohn's Disease Exclusion Diet (Med-CDED) | - | - | - | - | [1] 96 96 💬
|
| 896 | Medium chain triglycerides | - | - | - | - | [2] 96 96, 97 💬
|
| 897 | Medium dose TSO | - | - | - | - | [1] 96 96 💬
|
| 898 | Melatonin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬
| [2] MTNR1A MTNR1A, MTNR1B 💬
| [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [18] 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
|
| 899 | Melphalan | [1] Melphalan Melphalan | [2] Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | [19] 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
| 900 | Mensa | - | - | - | - | [1] 96 96 💬
|
| 901 | Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [4] 65 65, 96, 97, 164 💬
|
| 902 | Mesalamine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [3] 96 96, 97, 164 💬
|
| 903 | Mesalamine, 5-aminosalicylic acid | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] Aminosalicylic acid
Aminosalicylic acid
,
Mesalamine
💬
| - | - | [1] 96 96 💬
|
| 904 | Mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [3] 46 46, 96, 97 💬
|
| 905 | Mesalazine (Mesalamine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 96 96 💬
|
| 906 | Mesalazine EC 500 mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 96 96 💬
|
| 907 | Mesalazine Sustained-Release Tablets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 96 96 💬
|
| 908 | Mesalazine tablets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 96 96 💬
|
| 909 | Mesalazine, Tripterygium glycosides | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 96 96 💬
|
| 910 | Mesenchymal cell and fibroblast injection | - | - | - | - | [1] 96 96 💬
|
| 911 | Mesenchymal cell transplantation | - | - | - | - | [2] 46 46, 96 💬
|
| 912 | Mesenchymal stem cells | - | - | - | - | [16] 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
|
| 913 | Mesenchymal stem cells (MSC) | - | - | - | - | [3] 2 2, 13, 96 💬
|
| 914 | Mesenchymal stem cells (MSCs) | - | - | - | - | [4] 13 13, 36, 96, 97 💬
|
| 915 | Mesenchymal Stem CellsProduct Code: MSCPharmaceutical Form: Suspension for injectionPharmaceutical form of the placebo: Suspension for injectionRoute of administration of the placebo: Submucosal use | - | - | - | - | [1] 96 96 💬
|
| 916 | Mesenchymal stromal cells | - | - | - | - | [7] 36 36, 51, 96, 97, 107, 274, 284 💬
|
| 917 | Mesenchymal stromal cells (MSC) for infusion | - | - | - | - | [1] 96 96 💬
|
| 918 | Mesna | [1] Coenzyme M Coenzyme M | [1] Mesna
Mesna
💬
| - | - | [12] 11 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 919 | Methacholine | [1] Methacholine Methacholine | [1] Methacholine chloride
Methacholine chloride
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [2] 96 96, 340 💬
|
| 920 | Methotrexat | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [3] 13 13, 46, 96 💬
|
| 921 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 922 | METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 96 96 💬
|
| 923 | METHOTREXATE DISODIUM | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [5] 46 46, 96, 97, 107, 271 💬
|
| 924 | Methotrexate injection | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [2] 96 96, 97 💬
|
| 925 | Methoxsalen | [1] Methoxsalen Methoxsalen | [1] Methoxsalen
Methoxsalen
💬
| - | - | [3] 36 36, 46, 96 💬
|
| 926 | Methoxsalen +ECP | [1] Methoxsalen Methoxsalen | [1] Methoxsalen
Methoxsalen
💬
| - | - | [1] 96 96 💬
|
| 927 | Methyl prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 43 43, 49, 96 💬
|
| 928 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 929 | Methylprednisolone or budesonide | [2] Budesonide Budesonide, Methylprednisolone | [3] Budesonide
Budesonide
,
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 930 | METOJECT | - | - | - | - | [6] 41 41, 46, 96, 97, 107, 271 💬
|
| 931 | Metotrexat | - | - | - | - | [3] 50 50, 96, 97 💬
|
| 932 | Metronidazol | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [2] 46 46, 96 💬
|
| 933 | METRONIDAZOLE | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [7] 46 46, 51, 63, 94, 96, 97, 291 💬
|
| 934 | Metronidazole Oral | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [1] 96 96 💬
|
| 935 | MICROBIOTA | - | - | - | - | [1] 96 96 💬
|
| 936 | Midazolam | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [14] 2 2, 3, 6, 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
|
| 937 | Midazolam 2 mg | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 96 96, 97 💬
|
| 938 | Midazolam 3 mg | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 96 96 💬
|
| 939 | Mirikizumab | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 37 37, 96, 97 💬
|
| 940 | Mirikizumab (MIR) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 941 | Mirikizumab - Intravenous (IV) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 942 | Mirikizumab - IV | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 943 | Mirikizumab - SC | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 944 | Mirikizumab - Subcutaneous (SC) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 945 | MLN0002 | - | - | - | - | [3] 94 94, 96, 97 💬
|
| 946 | MLN0002 SC | - | - | - | - | [2] 96 96, 97 💬
|
| 947 | MLN002 | - | - | - | - | [2] 96 96, 97 💬
|
| 948 | Mobilization of stem cells to prepare for Leukapheresis | - | - | - | - | [1] 96 96 💬
|
| 949 | MODAFINIL | [1] Modafinil Modafinil | [1] Modafinil
Modafinil
💬
| - | - | [6] 6 6, 13, 49, 93, 96, 97 💬
|
| 950 | Moderate Oligosaccharide Group | - | - | - | - | [1] 96 96 💬
|
| 951 | Modulen | - | - | - | - | [1] 96 96 💬
|
| 952 | MODULEN IBD | - | - | - | - | [1] 96 96 💬
|
| 953 | MODULEN IBD (R) (specific Enteral Nutrition) | - | - | - | - | [1] 96 96 💬
|
| 954 | Mongersen | [1] Mongersen Mongersen | [1] Mongersen
Mongersen
💬
| [1] SMAD7 SMAD7 💬
| [2] Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | [2] 96 96, 97 💬
|
| 955 | Monoclonal antibodies | - | - | - | - | [1] 96 96 💬
|
| 956 | MONOCLONAL ANTIBODY ANTI-IGG1 | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 957 | Monoclonal antibody cA2 | - | - | - | - | [1] 96 96 💬
|
| 958 | MORF-057 | [1] MORF-057 MORF-057 | - | - | - | [2] 96 96, 97 💬
|
| 959 | Mosapride | [1] Mosapride Mosapride | [1] Mosapride
Mosapride
💬
| [1] HTR4 HTR4 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 96 96 💬
|
| 960 | Moviprep polvo para solución oral | - | - | - | - | [2] 96 96, 97 💬
|
| 961 | Movprep | - | - | - | - | [1] 96 96 💬
|
| 962 | MSC | - | - | - | - | [5] 51 51, 60, 96, 97, 271 💬
|
| 963 | MSC injection 01 | - | - | - | - | [1] 96 96 💬
|
| 964 | MSC injection 02 | - | - | - | - | [1] 96 96 💬
|
| 965 | MSC treatment 01 | - | - | - | - | [1] 96 96 💬
|
| 966 | MSC treatment 02 | - | - | - | - | [1] 96 96 💬
|
| 967 | MSC-AFP | - | - | - | - | [1] 96 96 💬
|
| 968 | MT-1303 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 969 | MT-201 | - | - | - | - | [2] 96 96, 97 💬
|
| 970 | MT-501 | - | - | - | - | [2] 96 96, 97 💬
|
| 971 | MTP-101C | - | - | - | - | [2] 2 2, 96 💬
|
| 972 | MTP-101S | - | - | - | - | [1] 96 96 💬
|
| 973 | MTX | - | - | - | - | [5] 40 40, 46, 60, 96, 107 💬
|
| 974 | MVA HAV | - | - | - | - | [1] 96 96 💬
|
| 975 | Mycodigest supplement | - | - | - | - | [2] 96 96, 97 💬
|
| 976 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 977 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [9] 11 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
|
| 978 | N-3 Polyunsaturated Fatty Acids | - | - | - | - | [1] 96 96 💬
|
| 979 | N-Acetylglucosamine | [1] N-Acetylglucosamine N-Acetylglucosamine | - | - | - | [1] 96 96 💬
|
| 980 | N-Acetylglucosamine (GlcNAc) | [1] N-Acetylglucosamine N-Acetylglucosamine | - | - | - | [1] 96 96 💬
|
| 981 | N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium | - | - | - | - | [1] 96 96 💬
|
| 982 | N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium | - | - | - | - | [1] 96 96 💬
|
| 983 | N.a. | - | - | - | - | [11] 3 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
|
| 984 | Naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [14] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
|
| 985 | NALTREXONE HYDROCHLORIDE | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
| 986 | Naltrexone-HCl | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 💬
|
| 987 | Nap | - | - | - | - | [2] 96 96, 240 💬
|
| 988 | NATALIZUMAB | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [5] 13 13, 15, 25, 46, 96 💬
|
| 989 | Neomycin | [1] Neomycin Neomycin | [3] Neomycin sulfate
Neomycin sulfate
,
Neomycin palmitate
,
Neomycin
💬
| - | - | [3] 96 96, 97, 296 💬
|
| 990 | Nessuno | - | - | - | - | [1] 96 96 💬
|
| 991 | NI-0401 (anti-CD3 mAB) | - | - | - | - | [1] 96 96 💬
|
| 992 | Nitazoxanide | [1] Nitazoxanide Nitazoxanide | [1] Nitazoxanide
Nitazoxanide
💬
| - | - | [3] 46 46, 96, 97 💬
|
| 993 | Nivolumab | [1] Nivolumab Nivolumab | [1] Nivolumab
Nivolumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 994 | NNC 0142-0000-0002 | - | - | - | - | [2] 46 46, 96 💬
|
| 995 | NNC0114-0006 | [1] NNC0114-0006 NNC0114-0006 | - | - | - | [3] 46 46, 49, 96 💬
|
| 996 | NNC0142-0000-0002 | - | - | - | - | [1] 96 96 💬
|
| 997 | NNC142-0002 | - | - | - | - | [1] 96 96 💬
|
| 998 | None | - | - | - | - | [14] 13 13, 46, 65, 84, 85, 96, 97, 106, 160, 161, 171, 222, 223, 299 💬
|
| 999 | None at this time | - | - | - | - | [2] 96 96, 140 💬
|
| 1000 | Normal Saline | - | - | - | - | [20] 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 71, 79, 94, 96, 97, 210, 211, 226, 276, 296, 299 💬
|
| 1001 | NORMIX*AD 12CPR RIV 200MG | - | - | - | - | [1] 96 96 💬
|
| 1002 | Now Foods L-Ornithine Capsules | [1] Ornithine Ornithine | [2] Ornithine
Ornithine
,
Ornithine aspartate
💬
| - | - | [1] 96 96 💬
|
| 1003 | NSP001 | - | - | - | - | [1] 96 96 💬
|
| 1004 | Nutraceutical Combination | - | - | - | - | [1] 96 96 💬
|
| 1005 | Nutrition treat | - | - | - | - | [1] 96 96 💬
|
| 1006 | Nutritional dietary intervention | - | - | - | - | [2] 96 96, 97 💬
|
| 1007 | NutropinAq 10mg/2ml solution for injection | - | - | - | - | [1] 96 96 💬
|
| 1008 | NutropinAq® | - | - | - | - | [1] 96 96 💬
|
| 1009 | Obefazimod | [1] Obefazimod Obefazimod | [1] Obefazimod
Obefazimod
💬
| [3] NCBP1 NCBP1, NCBP2, NCBP2L 💬
| [4] Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Nucleocytoplasmic transport, Spliceosome, mRNA surveillance pathway 💬 | [2] 96 96, 97 💬
|
| 1010 | OD-07656 | - | - | - | - | [3] 96 96, 97, 110 💬
|
| 1011 | OL adalimumab 40 mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1012 | Oligofructose enriched inulin | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [1] 96 96 💬
|
| 1013 | Olokizumab | [1] Olokizumab Olokizumab | [1] Olokizumab
Olokizumab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 46 46, 96 💬
|
| 1014 | Olokizumab (OKZ) | [1] Olokizumab Olokizumab | [1] Olokizumab
Olokizumab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 96 96 💬
|
| 1015 | Omegaven | - | - | - | - | [1] 96 96 💬
|
| 1016 | Omegaven 10% | - | - | - | - | [1] 96 96 💬
|
| 1017 | Omeprazol | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [2] 96 96, 294 💬
|
| 1018 | Omeprazole | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [18] 6 6, 8, 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
|
| 1019 | Omeprazole (proton pump inhibitor) | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 96 96 💬
|
| 1020 | Omeprazole 20 mg | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [2] 96 96, 97 💬
|
| 1021 | Omeprazole 40 mg | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 96 96 💬
|
| 1022 | Only 1 arm: treatment with MSC-AFP | - | - | - | - | [1] 96 96 💬
|
| 1023 | Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 💬
|
| 1024 | OPC-6535 | - | - | - | - | [2] 96 96, 97 💬
|
| 1025 | OPC-6535(Tetomilast) | [1] Tetomilast Tetomilast | - | - | - | [2] 96 96, 97 💬
|
| 1026 | OPS-2071 | - | - | - | - | [1] 96 96 💬
|
| 1027 | OPS-2071 150 mg | - | - | - | - | [1] 96 96 💬
|
| 1028 | OPS-2071 300 mg | - | - | - | - | [1] 96 96 💬
|
| 1029 | OPS-2071 600 mg | - | - | - | - | [1] 96 96 💬
|
| 1030 | Optimized Treatment (OPT) | - | - | - | - | [2] 96 96, 97 💬
|
| 1031 | Optison | - | - | - | - | [1] 96 96 💬
|
| 1032 | Oral contrast media application | - | - | - | - | [1] 96 96 💬
|
| 1033 | Oral prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 49 49, 96, 145 💬
|
| 1034 | ORENCIA | - | - | - | - | [16] 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
|
| 1035 | Originator (legacy) drug | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1036 | Ornithine | [1] Ornithine Ornithine | [2] Ornithine
Ornithine
,
Ornithine aspartate
💬
| - | - | [3] 96 96, 245, 251 💬
|
| 1037 | Ossium vBM-MSC | - | - | - | - | [1] 96 96 💬
|
| 1038 | OSSM-001 | - | - | - | - | [1] 96 96 💬
|
| 1039 | Other Biologic Therapies | - | - | - | - | [2] 96 96, 97 💬
|
| 1040 | Other biological agent | - | - | - | - | [2] 46 46, 96 💬
|
| 1041 | Other: 100% pomegranate juice | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 💬
|
| 1042 | Other: 5-ASA Withdrawal | - | - | - | - | [1] 96 96 💬
|
| 1043 | Other: Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 96 96 💬
|
| 1044 | Other: Advanced therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 1045 | Other: Biopsies | - | - | - | - | [1] 96 96 💬
|
| 1046 | Other: Biopsies, stool and blood collection | - | - | - | - | [1] 96 96 💬
|
| 1047 | Other: Biopsy and blood sampling | - | - | - | - | [1] 96 96 💬
|
| 1048 | Other: Blood and stool sample | - | - | - | - | [2] 96 96, 97 💬
|
| 1049 | Other: Blood draw | - | - | - | - | [17] 2 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
|
| 1050 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 1051 | Other: Blood Samples | - | - | - | - | [13] 3 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
|
| 1052 | Other: Blood sampling and biopsy | - | - | - | - | [1] 96 96 💬
|
| 1053 | Other: blood specimen | - | - | - | - | [4] 43 43, 96, 97, 329 💬
|
| 1054 | Other: Blood test | - | - | - | - | [11] 10 10, 19, 46, 51, 57, 65, 66, 83, 86, 96, 113 💬
|
| 1055 | Other: Blood tests, intestinal biopsies, stool samples, environmental exposure questionnaire and FFQ questionnaire | - | - | - | - | [1] 96 96 💬
|
| 1056 | Other: CDPATH™ | - | - | - | - | [1] 96 96 💬
|
| 1057 | Other: Clinical follow-up | - | - | - | - | [2] 96 96, 97 💬
|
| 1058 | Other: Coffee | - | - | - | - | [1] 96 96 💬
|
| 1059 | Other: colonoscopy | - | - | - | - | [2] 96 96, 97 💬
|
| 1060 | Other: Control | - | - | - | - | [12] 6 6, 19, 67, 70, 75, 85, 96, 97, 162, 193, 226, 296 💬
|
| 1061 | Other: Control Diet | - | - | - | - | [2] 96 96, 97 💬
|
| 1062 | Other: Crohn's disease activity index (CDAI) | - | - | - | - | [1] 96 96 💬
|
| 1063 | Other: Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 💬
|
| 1064 | Other: Crohns Disease Exclusion Diet | - | - | - | - | [1] 96 96 💬
|
| 1065 | Other: Digestible Maltodextrin | [1] Maltodextrin Maltodextrin | [1] Maltodextrin
Maltodextrin
💬
| - | - | [1] 96 96 💬
|
| 1066 | Other: Discontinuation of 5-ASA | - | - | - | - | [2] 96 96, 97 💬
|
| 1067 | Other: enteral nutrition | - | - | - | - | [1] 96 96 💬
|
| 1068 | Other: Exclusion Diet | - | - | - | - | [1] 96 96 💬
|
| 1069 | Other: Exclusive enteral nutrition | - | - | - | - | [1] 96 96 💬
|
| 1070 | Other: Fecal Microbial Transplantation | - | - | - | - | [2] 96 96, 97 💬
|
| 1071 | Other: Fecal Microbiota Transplantation | [1] Fecal microbiota Fecal microbiota | - | - | - | [3] 96 96, 97, 271 💬
|
| 1072 | Other: Fluorescence molecular imaging procedure without prior administration of vedolizumab-800CW | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1073 | Other: food questionnaire | - | - | - | - | [4] 46 46, 49, 96, 97 💬
|
| 1074 | Other: Fractional Exhaled NO (FENO) | - | - | - | - | [1] 96 96 💬
|
| 1075 | Other: Green tea (Camellia sinensis) | - | - | - | - | [1] 96 96 💬
|
| 1076 | Other: Groningen Anti-Inflammatory Diet (GrAID) | - | - | - | - | [1] 96 96 💬
|
| 1077 | Other: High energy / protein diet. | - | - | - | - | [1] 96 96 💬
|
| 1078 | Other: high performance liquid chromatography | - | - | - | - | [1] 96 96 💬
|
| 1079 | Other: Hyperbaric oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 96 96 💬
|
| 1080 | Other: IBD-AID diet | - | - | - | - | [1] 96 96 💬
|
| 1081 | Other: Ibuprofen | [1] Ibuprofen Ibuprofen | [5] Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 96 96 💬
|
| 1082 | Other: Indirect calorimetry, body composition , blood tests,3 days food records,Crohns disease activity index | - | - | - | - | [1] 96 96 💬
|
| 1083 | Other: infliximab (IFX) infusion | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1084 | Other: Intensify treatment with the existing drug | - | - | - | - | [2] 96 96, 97 💬
|
| 1085 | Other: IV saline infusion | - | - | - | - | [1] 96 96 💬
|
| 1086 | Other: Laboratory Biomarker Analysis | - | - | - | - | [22] 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 1087 | Other: Lengthening adalimumab dosing interval | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1088 | Other: Leukapheresis- Collection of stem cells | - | - | - | - | [1] 96 96 💬
|
| 1089 | Other: Local injection of normal saline | - | - | - | - | [1] 96 96 💬
|
| 1090 | Other: Low n-6 PUFA Diet | - | - | - | - | [1] 96 96 💬
|
| 1091 | Other: Measurement of drug (Adalimumab/Infliximab) | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1092 | Other: Methacholine Challenge Test | [1] Methacholine Methacholine | [1] Methacholine chloride
Methacholine chloride
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 96 96 💬
|
| 1093 | Other: No intervention | - | - | - | - | [5] 6 6, 70, 96, 97, 201 💬
|
| 1094 | Other: normal diet | - | - | - | - | [2] 96 96, 97 💬
|
| 1095 | Other: NS | - | - | - | - | [1] 96 96 💬
|
| 1096 | Other: Other Biologic Agents | - | - | - | - | [2] 96 96, 97 💬
|
| 1097 | Other: PCDAI | - | - | - | - | [1] 96 96 💬
|
| 1098 | Other: polyethylene glycol preparation | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 96 96 💬
|
| 1099 | Other: Quality-of-Life Assessment | - | - | - | - | [9] 34 34, 36, 51, 62, 65, 96, 284, 286, 298 💬
|
| 1100 | Other: Questionnaires | - | - | - | - | [8] 3 3, 6, 13, 41, 46, 77, 96, 226 💬
|
| 1101 | Other: Removal of blood | - | - | - | - | [2] 96 96, 97 💬
|
| 1102 | Other: Sham Diet | - | - | - | - | [2] 96 96, 97 💬
|
| 1103 | Other: Sham transplantation | - | - | - | - | [2] 96 96, 97 💬
|
| 1104 | Other: SoC corticosteroid - Induction Period | - | - | - | - | [1] 96 96 💬
|
| 1105 | Other: SoC corticosteroid - Tapering | - | - | - | - | [1] 96 96 💬
|
| 1106 | Other: Standard medical treatment | - | - | - | - | [6] 13 13, 96, 97, 149, 153, 171 💬
|
| 1107 | Other: Standard nutrition | - | - | - | - | [1] 96 96 💬
|
| 1108 | Other: Standard of Care | - | - | - | - | [11] 13 13, 49, 57, 64, 79, 85, 95, 96, 97, 245, 246 💬
|
| 1109 | Other: Stem Cell Transplant | - | - | - | - | [1] 96 96 💬
|
| 1110 | Other: Stool samples | - | - | - | - | [3] 51 51, 96, 97 💬
|
| 1111 | Other: Surgery | - | - | - | - | [2] 74 74, 96 💬
|
| 1112 | Other: Threonine | [1] Threonine Threonine | [1] Threonine
Threonine
💬
| - | - | [2] 96 96, 97 💬
|
| 1113 | Other: triangular test | - | - | - | - | [1] 96 96 💬
|
| 1114 | Other: UC-MSCs by peripheral intravenous infusion | - | - | - | - | [1] 96 96 💬
|
| 1115 | Other: VOCs profile | - | - | - | - | [2] 96 96, 97 💬
|
| 1116 | Other: Water | [1] Water Water | [1] Water
Water
💬
| - | - | [3] 67 67, 96, 240 💬
|
| 1117 | Other: water preparation | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 96 96 💬
|
| 1118 | Ova-Treg | - | - | - | - | [1] 96 96 💬
|
| 1119 | Ovasave | - | - | - | - | [1] 96 96 💬
|
| 1120 | Oxadrop | - | - | - | - | [1] 96 96 💬
|
| 1121 | Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [30] 6 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
|
| 1122 | Oxygen Gas for Inhalation | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [2] 96 96, 97 💬
|
| 1123 | Ozanimod | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 1124 | Ozanimod HCL | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 1125 | Ozanimod hydrochloride | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 1126 | P28GST | - | - | - | - | [1] 96 96 💬
|
| 1127 | PALI-2108 | - | - | - | - | [2] 96 96, 97 💬
|
| 1128 | Palifermin | [1] Palifermin Palifermin | [1] Palifermin
Palifermin
💬
| [1] FGFR2 FGFR2 💬
| [12] Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | [6] 13 13, 36, 38, 39, 65, 96 💬
|
| 1129 | Palmitoleic Acid | [1] Palmitoleic Acid Palmitoleic Acid | - | - | - | [2] 96 96, 97 💬
|
| 1130 | Palmitoleic Acid + Infliximab | [2] Infliximab Infliximab, Palmitoleic Acid | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1131 | Pancrelipase | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [4] 96 96, 97, 298, 299 💬
|
| 1132 | Partial Enteral Nutrition | - | - | - | - | [2] 96 96, 271 💬
|
| 1133 | Partial enteral nutrition - orally consumed formula | - | - | - | - | [1] 96 96 💬
|
| 1134 | PDA001 | - | - | - | - | [2] 46 46, 96 💬
|
| 1135 | Pectin | [1] Pectin Pectin | [1] Pectin
Pectin
💬
| - | - | [2] 96 96, 97 💬
|
| 1136 | Pegylated interferon alfa | [1] Interferon alfa Interferon alfa | [1] Interferon alfa
Interferon alfa
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 96 96 💬
|
| 1137 | Pending | - | - | - | - | [7] 6 6, 13, 19, 96, 97, 113, 302 💬
|
| 1138 | Pentasa | - | - | - | - | [2] 96 96, 97 💬
|
| 1139 | PENTASA Sachet | - | - | - | - | [2] 96 96, 97 💬
|
| 1140 | Pentasa Sachet 1 g | - | - | - | - | [2] 96 96, 97 💬
|
| 1141 | Pentasa Sachet 1 g prolonged release granules | - | - | - | - | [1] 96 96 💬
|
| 1142 | Pentoxifylline | [1] Pentoxifylline Pentoxifylline | [1] Pentoxifylline
Pentoxifylline
💬
| - | - | [13] 6 6, 26, 46, 56, 84, 93, 96, 97, 113, 222, 223, 296, 298 💬
|
| 1143 | Peptidic+Probiotic | - | - | - | - | [1] 96 96 💬
|
| 1144 | Peptison liquid | - | - | - | - | [1] 96 96 💬
|
| 1145 | Peripheral Blood Stem Cell Infusion | - | - | - | - | [1] 96 96 💬
|
| 1146 | PF 06687234 | - | - | - | - | [2] 96 96, 97 💬
|
| 1147 | PF-00547659 | - | - | - | - | [2] 96 96, 97 💬
|
| 1148 | PF-00547659 SC injection | - | - | - | - | [2] 96 96, 97 💬
|
| 1149 | PF-04236921 | - | - | - | - | [2] 49 49, 96 💬
|
| 1150 | PF-04236921 SC injection | - | - | - | - | [1] 96 96 💬
|
| 1151 | PF-06651600 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1152 | PF-06651600 50 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 1153 | PF-06651600 50mg | - | - | - | - | [1] 96 96 💬
|
| 1154 | PF-06651600-15 | - | - | - | - | [2] 96 96, 97 💬
|
| 1155 | PF-06700841 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1156 | PF-06700841 25 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 1157 | PF-06700841 5 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 1158 | PF-06700841-15 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1159 | PF2020-CELL (UC-MSCs) - Allogeneic Human Umbilical Cord Mesenchymal Stem Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 96 96 💬
|
| 1160 | Pharmacokinetics of certolizumab pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 💬
|
| 1161 | Phase1 : CDED/Modulen™IBD® + Maintenance therapy | - | - | - | - | [1] 96 96 💬
|
| 1162 | Phase2 and 3 : | - | - | - | - | [1] 96 96 💬
|
| 1163 | Phylloquinone | [1] Phylloquinone Phylloquinone | [1] Phytonadione
Phytonadione
💬
| - | - | [1] 96 96 💬
|
| 1164 | Phylloquinone (vitamin K1) | [1] Phylloquinone Phylloquinone | [1] Phytonadione
Phytonadione
💬
| - | - | [1] 96 96 💬
|
| 1165 | Physician standard-of-care | - | - | - | - | [1] 96 96 💬
|
| 1166 | Pioglitazone | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
|
| 1167 | Pioglitazone 15 mg | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 96 96 💬
|
| 1168 | PK-model to decide when to dose Vedolizumab and Ustekinumab | [2] Ustekinumab Ustekinumab, Vedolizumab | [2] Vedolizumab
Vedolizumab
,
Ustekinumab
💬
| [5] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7 💬
| [45] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1169 | PL 17901/0122 | - | - | - | - | [1] 96 96 💬
|
| 1170 | PL 20532/0012 | - | - | - | - | [1] 96 96 💬
|
| 1171 | Plantain NSP | - | - | - | - | [1] 96 96 💬
|
| 1172 | PLAQUENIL | - | - | - | - | [6] 46 46, 48, 49, 53, 84, 96 💬
|
| 1173 | Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI) | - | - | - | - | [1] 96 96 💬
|
| 1174 | Platinum | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 1175 | Platinum Compound | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 1176 | Platinum Doublet | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 1177 | Pnemovax | - | - | - | - | [1] 96 96 💬
|
| 1178 | Pneumovax | - | - | - | - | [5] 46 46, 49, 62, 96, 223 💬
|
| 1179 | Polaprezinc | [1] Polaprezinc Polaprezinc | [1] Polaprezinc
Polaprezinc
💬
| - | - | [2] 96 96, 97 💬
|
| 1180 | Polyethylene glycol | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [8] 6 6, 50, 96, 97, 195, 235, 276, 299 💬
|
| 1181 | Polyethylene Glycol 3350 | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [2] 96 96, 299 💬
|
| 1182 | Pomegranate | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 💬
|
| 1183 | Posaconazole | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [4] 60 60, 65, 96, 299 💬
|
| 1184 | Posaconazole Delayed Release Oral Tablet | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [1] 96 96 💬
|
| 1185 | Positron Emission Tomography | - | - | - | - | [6] 26 26, 28, 40, 46, 49, 96 💬
|
| 1186 | Postoperative 3-month exclusive enteral nutrition | - | - | - | - | [1] 96 96 💬
|
| 1187 | PRA023 | - | - | - | - | [3] 51 51, 96, 97 💬
|
| 1188 | PRA023 IV | - | - | - | - | [1] 96 96 💬
|
| 1189 | Pravastatin | [1] Pravastatin Pravastatin | [2] Pravastatin sodium
Pravastatin sodium
,
Pravastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [11] 13 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬
|
| 1190 | Prebiotic | - | - | - | - | [2] 96 96, 97 💬
|
| 1191 | Prebiotics | - | - | - | - | [2] 96 96, 97 💬
|
| 1192 | Precedentemente denominato MEDI2070 e AMG 139 | - | - | - | - | [1] 96 96 💬
|
| 1193 | Prednisolon | - | - | - | - | [11] 46 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
|
| 1194 | Prednisolon Jenapharm | - | - | - | - | [2] 96 96, 97 💬
|
| 1195 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 1196 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 1197 | Prednisone/Methylprenisolone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1198 | Preparative regimen 4-6 weeks after Leukapheresis | - | - | - | - | [1] 96 96 💬
|
| 1199 | Prevenar 13 | - | - | - | - | [5] 13 13, 46, 96, 97, 223 💬
|
| 1200 | Previously referred to as MEDI2070 and AMG 139 | - | - | - | - | [2] 96 96, 97 💬
|
| 1201 | Previously referred to as MEDI2070 and AMG 139, AGN-151-598 | - | - | - | - | [1] 96 96 💬
|
| 1202 | Probiotic | - | - | - | - | [10] 2 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
|
| 1203 | Probiotic - VSL#3 | - | - | - | - | [2] 96 96, 97 💬
|
| 1204 | Probiotic Mixture | - | - | - | - | [2] 96 96, 97 💬
|
| 1205 | Probiotics | - | - | - | - | [6] 6 6, 94, 96, 97, 206, 291 💬
|
| 1206 | PROCHYMAL (remestemcel-L) | [1] Remestemcel-L Remestemcel-L | [1] Remestemcel-L
Remestemcel-L
💬
| - | - | [1] 96 96 💬
|
| 1207 | PROCHYMAL adult human mesenchymal stem cells | - | - | - | - | [1] 96 96 💬
|
| 1208 | Prochymal® | - | - | - | - | [1] 96 96 💬
|
| 1209 | Prochymal™ adult human mesenchymal stem cells | - | - | - | - | [1] 96 96 💬
|
| 1210 | Promethazine | [1] Promethazine Promethazine | [3] Promethazine hydrochloride
Promethazine hydrochloride
,
Promethazine
,
Promethazine teoclate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [2] 6 6, 96 💬
|
| 1211 | PRUCALOPRIDE | [1] Prucalopride Prucalopride | [2] Prucalopride
Prucalopride
,
Prucalopride succinate
💬
| [1] HTR4 HTR4 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [3] 13 13, 51, 96 💬
|
| 1212 | PRV-6527 | - | - | - | - | [1] 96 96 💬
|
| 1213 | PRV-6527 (JNJ-40346527) | - | - | - | - | [1] 96 96 💬
|
| 1214 | PRV-6527(JNJ-40346527) | - | - | - | - | [1] 96 96 💬
|
| 1215 | PTG-200 | - | - | - | - | [1] 96 96 💬
|
| 1216 | Puri Nethol | - | - | - | - | [2] 96 96, 97 💬
|
| 1217 | Puri-Nethol | - | - | - | - | [3] 86 86, 96, 97 💬
|
| 1218 | Puri-Nethol 50 mg | - | - | - | - | [1] 96 96 💬
|
| 1219 | PURINETHOL | - | - | - | - | [1] 96 96 💬
|
| 1220 | PURINETHOL - 50 MG COMPRESSE25 COMPRESSE | - | - | - | - | [1] 96 96 💬
|
| 1221 | QAX567 | - | - | - | - | [1] 96 96 💬
|
| 1222 | QAX576 | - | - | - | - | [4] 51 51, 85, 96, 98 💬
|
| 1223 | QBECO | - | - | - | - | [2] 96 96, 97 💬
|
| 1224 | QBECO-SSI | - | - | - | - | [1] 96 96 💬
|
| 1225 | Rabbit | [1] Rabbit Rabbit | - | - | - | [11] 11 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
|
| 1226 | Rabbit anti-human thymocyte immunoglobulin | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 96 💬
|
| 1227 | Rabbit antithymocyte globulin | [1] Rabbit Rabbit | - | - | - | [3] 49 49, 60, 96 💬
|
| 1228 | RAD001 | - | - | - | - | [6] 34 34, 67, 89, 96, 158, 228 💬
|
| 1229 | Radiation: Fluorine F 18 Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬
| [3] POLA1 POLA1, POLA2, RRM1 💬
| [5] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [4] 40 40, 46, 49, 96 💬
|
| 1230 | Radiation: Total Body Irradiation | - | - | - | - | [11] 19 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
|
| 1231 | Radiation: total-body irradiation | - | - | - | - | [9] 28 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
|
| 1232 | Radiotracer Injection | - | - | - | - | [2] 94 94, 96 💬
|
| 1233 | Ranolazine | [1] Ranolazine Ranolazine | [2] Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | [8] 2 2, 57, 58, 86, 96, 97, 113, 114 💬
|
| 1234 | Rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [13] 2 2, 15, 49, 51, 53, 60, 63, 67, 96, 158, 256, 278, 279 💬
|
| 1235 | Raptiva 100 mg/ml powder and solvent for solution for injection | - | - | - | - | [9] 11 11, 13, 46, 48, 53, 61, 95, 96, 221 💬
|
| 1236 | RbATG | - | - | - | - | [2] 51 51, 96 💬
|
| 1237 | RCTB-401 | - | - | - | - | [2] 96 96, 97 💬
|
| 1238 | RD06-05 CART Cell Infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 1239 | Received hormone maintenance therapy | - | - | - | - | [1] 96 96 💬
|
| 1240 | Recombinant growth hormone | - | - | - | - | [1] 96 96 💬
|
| 1241 | Recombinant human Insulin-like Growth Factor | - | - | - | - | [1] 96 96 💬
|
| 1242 | Recombinant Human Interleukin-11 (rhIL-11) | - | - | - | - | [2] 96 96, 97 💬
|
| 1243 | Remestemcel-L | [1] Remestemcel-L Remestemcel-L | [1] Remestemcel-L
Remestemcel-L
💬
| - | - | [2] 96 96, 97 💬
|
| 1244 | REMICADE | - | - | - | - | [9] 46 46, 49, 56, 84, 85, 96, 97, 223, 271 💬
|
| 1245 | REMICADE (INFLIXIMAB) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 1246 | Remicade 100 mg | - | - | - | - | [2] 56 56, 96 💬
|
| 1247 | Remicade 100 mg powder for concentrate for solution for infusion. | - | - | - | - | [2] 96 96, 97 💬
|
| 1248 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1249 | RemicadePharmaceutical Form: Powder for injection*INN or Proposed INN: INFLIXIMABCAS Number: 170277313Concentration unit: mg/kg milligram(s)/kilogramConcentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 96 96 💬
|
| 1250 | Remifentanil | [1] Remifentanil Remifentanil | [2] Remifentanil hydrochloride
Remifentanil hydrochloride
,
Remifentanil
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [4] 6 6, 22, 70, 96 💬
|
| 1251 | Remisma | - | - | - | - | [1] 96 96 💬
|
| 1252 | REMSIMA | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1253 | Remsima (infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 1254 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1255 | Remsima 100 mg powder for solution for infusion | - | - | - | - | [1] 96 96 💬
|
| 1256 | Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1257 | REMSIMA 120 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 96 96 💬
|
| 1258 | Remsima and Inflectra | - | - | - | - | [2] 96 96, 97 💬
|
| 1259 | REMSINA | - | - | - | - | [1] 96 96 💬
|
| 1260 | Repetitive transcranial magnetic stimulation | - | - | - | - | [1] 96 96 💬
|
| 1261 | Rhamnose | [1] Rhamnose Rhamnose | - | - | - | [1] 96 96 💬
|
| 1262 | RHB-104 | - | - | - | - | [2] 13 13, 96 💬
|
| 1263 | RhIGF (Increlex) | - | - | - | - | [1] 96 96 💬
|
| 1264 | RhumAb to Il-17A (IgG1-k-class) | - | - | - | - | [4] 13 13, 46, 56, 96 💬
|
| 1265 | RhumAb to Il-17A (IgG1-k-class) rhumAb to Il-17A (IgG1-k-class) | - | - | - | - | [1] 96 96 💬
|
| 1266 | RIBAVIRIN | [1] Ribavirin Ribavirin | [1] Ribavirin
Ribavirin
💬
| - | - | [2] 2 2, 96 💬
|
| 1267 | Riboflavin | [1] Riboflavin Riboflavin | [1] Riboflavin
Riboflavin
💬
| - | - | [8] 13 13, 38, 46, 96, 97, 162, 168, 265 💬
|
| 1268 | Riboflavin sodium phosphate | [2] Flavin mononucleotide Flavin mononucleotide, Riboflavin | [2] Riboflavin
Riboflavin
,
Riboflavin sodium phosphate
💬
| - | - | [1] 96 96 💬
|
| 1269 | Riboflavin Sodium Phosphate Injection | [2] Flavin mononucleotide Flavin mononucleotide, Riboflavin | [2] Riboflavin
Riboflavin
,
Riboflavin sodium phosphate
💬
| - | - | [1] 96 96 💬
|
| 1270 | Riboflavin supplementation | [1] Riboflavin Riboflavin | [1] Riboflavin
Riboflavin
💬
| - | - | [1] 96 96 💬
|
| 1271 | RIFABUTIN | [1] Rifabutin Rifabutin | [1] Rifabutin
Rifabutin
💬
| - | - | [2] 96 96, 299 💬
|
| 1272 | Rifabutin, Clarithromycin, and Clofazimine | [3] Clarithromycin Clarithromycin, Clofazimine, Rifabutin | [3] Clarithromycin
Clarithromycin
,
Clofazimine
,
Rifabutin
💬
| - | - | [1] 96 96 💬
|
| 1273 | Rifaximin | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [8] 6 6, 65, 93, 96, 97, 99, 296, 299 💬
|
| 1274 | Rifaximin Delayed Release (DR) | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [1] 96 96 💬
|
| 1275 | Rifaximin delayed release 400 mg film coated tablet | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [1] 96 96 💬
|
| 1276 | Rifaximin delayed release tablets | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [1] 96 96 💬
|
| 1277 | Rifaximin EIR | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [1] 96 96 💬
|
| 1278 | Rifaximin+omeprazole+miralax | [2] Omeprazole Omeprazole, Rifaximin | [4] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Rifaximin
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 96 96 💬
|
| 1279 | Rifaximin-EIR | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [1] 96 96 💬
|
| 1280 | RIFAXIMINA | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [1] 96 96 💬
|
| 1281 | Risankizumab | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [4] 37 37, 96, 97, 271 💬
|
| 1282 | Risankizumab (RISA) | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 1283 | Risankizumab 10 mg/ml | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 1284 | Risankizumab 180 mg SC | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 1285 | Risankizumab 600 mg IV | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 1286 | Risankizumab 90 mg/ml | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 1287 | Risankizumab IV | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1288 | Risankizumab On-Body Injector (OBI) | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 1289 | Risankizumab SC | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1290 | Risankizumab-800CW 15 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1291 | Risankizumab-800CW 15 mg/25 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1292 | Risankizumab-800CW 25 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1293 | Risankizumab-800CW 4.5 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1294 | Risankizumab-800CW optimal dose | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1295 | Risedronate | [1] Risedronic acid Risedronic acid | [3] Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [2] 96 96, 113 💬
|
| 1296 | Ritlecitinib | [1] Ritlecitinib Ritlecitinib | [1] Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| [1] JAK3 JAK3 💬
| [15] Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | [3] 46 46, 96, 97 💬
|
| 1297 | Ritlecitinib 50 mg | [1] Ritlecitinib Ritlecitinib | [1] Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| [1] JAK3 JAK3 💬
| [15] Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | [2] 96 96, 97 💬
|
| 1298 | Ritlecitinib 50mg | [1] Ritlecitinib Ritlecitinib | [1] Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| [1] JAK3 JAK3 💬
| [15] Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | [1] 96 96 💬
|
| 1299 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 1300 | Rizankisumab | - | - | - | - | [1] 96 96 💬
|
| 1301 | Rizankizumab | - | - | - | - | [1] 96 96 💬
|
| 1302 | Ro 549-0261/F04-02 | - | - | - | - | [1] 96 96 💬
|
| 1303 | Ro 549-0261/F08-02 | - | - | - | - | [1] 96 96 💬
|
| 1304 | Ro549-0261/F04-02 | - | - | - | - | [1] 96 96 💬
|
| 1305 | RoadMAB | - | - | - | - | [1] 96 96 💬
|
| 1306 | RoadMAB precision dashboard | - | - | - | - | [1] 96 96 💬
|
| 1307 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [16] 6 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
|
| 1308 | Rosuvastatin 10 mg | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 96 96 💬
|
| 1309 | Routine drainage surgery | - | - | - | - | [1] 96 96 💬
|
| 1310 | Routine Treatment of CD | - | - | - | - | [1] 96 96 💬
|
| 1311 | RPC0163 | - | - | - | - | [1] 96 96 💬
|
| 1312 | RPC1063 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 1313 | RPC1063 (equivalent to ozanimod | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 1314 | RPC1063 (equivalent to ozanimod HCl) | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 1315 | RR110 (Tamibarotene) | [1] Tamibarotene Tamibarotene | [1] Tamibarotene
Tamibarotene
💬
| [1] RARA RARA 💬
| [5] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 96 96 💬
|
| 1316 | RVG 05565 | - | - | - | - | [1] 96 96 💬
|
| 1317 | RVG 07151 | - | - | - | - | [1] 96 96 💬
|
| 1318 | RVG 114681 | - | - | - | - | [2] 96 96, 97 💬
|
| 1319 | RVG 116648 | - | - | - | - | [2] 96 96, 97 💬
|
| 1320 | RVG00859 | - | - | - | - | [2] 96 96, 97 💬
|
| 1321 | RVT-3101 | - | - | - | - | [1] 96 96 💬
|
| 1322 | RYAH-Medtech Inhaler | - | - | - | - | [5] 2 2, 6, 13, 96, 97 💬
|
| 1323 | S38 | - | - | - | - | [1] 96 96 💬
|
| 1324 | Salofalk | - | - | - | - | [2] 96 96, 97 💬
|
| 1325 | Salofalk 500 mg | - | - | - | - | [1] 96 96 💬
|
| 1326 | Sandostatine | - | - | - | - | [1] 96 96 💬
|
| 1327 | SAR441566 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1328 | SAR442970 | - | - | - | - | [2] 96 96, 97 💬
|
| 1329 | Sargramostim | [1] Sargramostim Sargramostim | [1] Sargramostim
Sargramostim
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [7] 6 6, 28, 60, 62, 96, 229, 285 💬
|
| 1330 | Sargramostim (Leukine) | [1] Sargramostim Sargramostim | [1] Sargramostim
Sargramostim
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 96 96 💬
|
| 1331 | SB5 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 1332 | SC Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 1333 | SC12267 | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬
|
| 1334 | SC12267 (4SC-101) | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬
|
| 1335 | Search for exocrine pancreatic insufficiency at week 0 and 12 | - | - | - | - | [1] 96 96 💬
|
| 1336 | Selective Immunosuppressive agents | - | - | - | - | [1] 96 96 💬
|
| 1337 | Selective intensive induction therapy based on ustekinumab clinical decision-making tools | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1338 | Selenium | [1] Selenium Selenium | - | - | - | [5] 13 13, 96, 97, 278, 298 💬
|
| 1339 | Semapimod | [1] Semapimod Semapimod | - | - | - | [1] 96 96 💬
|
| 1340 | Serine | [1] Serine Serine | [1] Serine
Serine
💬
| - | - | [5] 2 2, 6, 86, 96, 222 💬
|
| 1341 | SERUM ALBUMINE 5% | - | - | - | - | [1] 96 96 💬
|
| 1342 | Serum bovine immunoglobulin | - | - | - | - | [2] 96 96, 97 💬
|
| 1343 | Serum physiologique 0.9 % | - | - | - | - | [1] 96 96 💬
|
| 1344 | Seton Placement | - | - | - | - | [1] 96 96 💬
|
| 1345 | Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane | - | - | - | - | [1] 96 96 💬
|
| 1346 | Shingrix | - | - | - | - | [6] 41 41, 46, 49, 51, 96, 97 💬
|
| 1347 | SHP647 | - | - | - | - | [2] 96 96, 97 💬
|
| 1348 | SHR0302 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1349 | Sibofimloc | [1] Sibofimloc Sibofimloc | [1] Sibofimloc
Sibofimloc
💬
| - | - | [1] 96 96 💬
|
| 1350 | Simethicone | [1] Simethicone Simethicone | [1] Simethicone
Simethicone
💬
| - | - | [2] 13 13, 96 💬
|
| 1351 | Sivelestat | [1] Sivelestat Sivelestat | [1] Sivelestat
Sivelestat
💬
| [1] ELANE ELANE 💬
| [4] Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Phagocytosis, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | [3] 13 13, 85, 96 💬
|
| 1352 | Small bowel follow trough | - | - | - | - | [1] 96 96 💬
|
| 1353 | SMOFLipid | - | - | - | - | [1] 96 96 💬
|
| 1354 | Smoking cigarettes | - | - | - | - | [2] 96 96, 97 💬
|
| 1355 | Smoking of cannabis | - | - | - | - | [2] 96 96, 97 💬
|
| 1356 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 1357 | Solid food-based intervention | - | - | - | - | [1] 96 96 💬
|
| 1358 | Somatropin [rDNA origin] for injection | - | - | - | - | [2] 46 46, 96 💬
|
| 1359 | Somatropin(rhGH) | - | - | - | - | [1] 96 96 💬
|
| 1360 | Sonazoid | - | - | - | - | [1] 96 96 💬
|
| 1361 | SonoVue | - | - | - | - | [2] 96 96, 97 💬
|
| 1362 | Soy protein | - | - | - | - | [2] 6 6, 96 💬
|
| 1363 | Soya Bean oil | [1] Bean Bean | - | - | - | [1] 96 96 💬
|
| 1364 | Spesolilmab | - | - | - | - | [1] 96 96 💬
|
| 1365 | Spesolimab | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [5] 37 37, 96, 97, 160, 269 💬
|
| 1366 | ST10 | - | - | - | - | [2] 96 96, 97 💬
|
| 1367 | ST10-021 | - | - | - | - | [2] 96 96, 97 💬
|
| 1368 | STA-5326 | - | - | - | - | [2] 65 65, 96 💬
|
| 1369 | STA-5326 mesylate | - | - | - | - | [1] 96 96 💬
|
| 1370 | STA-6838, STA-5326 m, S38 | - | - | - | - | [1] 96 96 💬
|
| 1371 | Stable isotope infusions | - | - | - | - | [1] 96 96 💬
|
| 1372 | Standard 2 hours-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 1373 | Standard clear liquid diet | - | - | - | - | [1] 96 96 💬
|
| 1374 | Standard infliximab intravenous therapy | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1375 | Standard of Care | - | - | - | - | [18] 6 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
|
| 1376 | Standard of Care Treatment | - | - | - | - | [6] 11 11, 49, 53, 96, 245, 246 💬
|
| 1377 | Standard step-up care | - | - | - | - | [1] 96 96 💬
|
| 1378 | Standard-Dose Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1379 | Standard-Dose infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1380 | Standart of care | - | - | - | - | [1] 96 96 💬
|
| 1381 | Start adalimumab in monotherapy | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1382 | Stelara | - | - | - | - | [6] 49 49, 56, 96, 97, 269, 271 💬
|
| 1383 | STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 1384 | STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML | - | - | - | - | [2] 96 96, 97 💬
|
| 1385 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 1386 | STELARA 130 mg concentrate for solution for infusion | - | - | - | - | [1] 96 96 💬
|
| 1387 | Stelara 130mg / 26mL concentrate for solution for infusion | - | - | - | - | [1] 96 96 💬
|
| 1388 | Stelara 45 mg solution for injection | - | - | - | - | [1] 96 96 💬
|
| 1389 | STELARA 90 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 96 96 💬
|
| 1390 | Stelara 90 mg solution for injection n pre-filled syringue | - | - | - | - | [1] 96 96 💬
|
| 1391 | Stelara 90mg/1ml solution for injection in pre-filled syringe (PFS) | - | - | - | - | [1] 96 96 💬
|
| 1392 | Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra | - | - | - | - | [1] 96 96 💬
|
| 1393 | STELARA® | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1394 | STELARA®Product Name: UstekinumabProduct Code: CNTO1275Pharmaceutical Form: Solution for injectionINN or Proposed INN: UstekinumabCAS Number: 815610-63-0Current Sponsor code: CNTO1275Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: up toConcentration number: 200-Trade Name: STELARA®Product Name: UstekinumabProduct Code: CNTO1275Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: UstekinumabCAS Number: 815610-63-0Current Sponsor code: CNTO1275Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: up toConcentration number: 200- | - | - | - | - | [2] 96 96, 97 💬
|
| 1395 | STELARA¿ | - | - | - | - | [1] 96 96 💬
|
| 1396 | Stem Cells | - | - | - | - | [4] 2 2, 4, 96, 113 💬
|
| 1397 | Step-up | - | - | - | - | [1] 96 96 💬
|
| 1398 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 💬
|
| 1399 | Stool simple | - | - | - | - | [1] 96 96 💬
|
| 1400 | Stromal vascular fraction (SVF) | - | - | - | - | [2] 71 71, 96 💬
|
| 1401 | SUB20016 | - | - | - | - | [2] 96 96, 97 💬
|
| 1402 | Sucrose | [1] Sucrose Sucrose | [1] Sucrose
Sucrose
💬
| - | - | [4] 62 62, 96, 97, 127 💬
|
| 1403 | Sugar Extract | - | - | - | - | [2] 96 96, 97 💬
|
| 1404 | SULFUR HEXAFLUORIDE | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | [3] 96 96, 97, 215 💬
|
| 1405 | Sulphur hexafluoride | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | [2] 96 96, 97 💬
|
| 1406 | Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬
|
| 1407 | Suspension containing 250 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬
|
| 1408 | Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬
|
| 1409 | Suspension containing 2500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬
|
| 1410 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬
|
| 1411 | Suspension of 7500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬
|
| 1412 | Suspension of adipose derived autologous adult stem cells | - | - | - | - | [2] 96 96, 97 💬
|
| 1413 | Switch of anti TNF for ustekinumab for paradoxical psoriasis. | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1414 | Synbiotic | - | - | - | - | [2] 49 49, 96 💬
|
| 1415 | Synbiotic (Synergy I / B.longum) | - | - | - | - | [1] 96 96 💬
|
| 1416 | T2 | - | - | - | - | [1] 96 96 💬
|
| 1417 | TA-650 | - | - | - | - | [4] 37 37, 56, 96, 97 💬
|
| 1418 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 1419 | TAK-018 | - | - | - | - | [1] 96 96 💬
|
| 1420 | TAK-279 | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 1421 | Tamibarotene | [1] Tamibarotene Tamibarotene | [1] Tamibarotene
Tamibarotene
💬
| [1] RARA RARA 💬
| [5] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [3] 26 26, 67, 96 💬
|
| 1422 | Tasty&Healthy intervention group | - | - | - | - | [1] 96 96 💬
|
| 1423 | TBC | - | - | - | - | [4] 85 85, 94, 96, 127 💬
|
| 1424 | TD-1473 | - | - | - | - | [2] 96 96, 97 💬
|
| 1425 | TDM-based infliximab intravenous therapy | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1426 | Teduglutide | [1] Teduglutide Teduglutide | [1] Teduglutide
Teduglutide
💬
| [1] GLP2R GLP2R 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1427 | Teduglutide (ALX-0600) | [1] Teduglutide Teduglutide | [1] Teduglutide
Teduglutide
💬
| [1] GLP2R GLP2R 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1428 | Teduglutide 0.05 | [1] Teduglutide Teduglutide | [1] Teduglutide
Teduglutide
💬
| [1] GLP2R GLP2R 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1429 | Teduglutide 0.05 dose | [1] Teduglutide Teduglutide | [1] Teduglutide
Teduglutide
💬
| [1] GLP2R GLP2R 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1430 | Teduglutide 0.1 mg dose | [1] Teduglutide Teduglutide | [1] Teduglutide
Teduglutide
💬
| [1] GLP2R GLP2R 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1431 | Teduglutide 0.2 mg | [1] Teduglutide Teduglutide | [1] Teduglutide
Teduglutide
💬
| [1] GLP2R GLP2R 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1432 | Tempeh Isoflavone | [1] Isoflavone Isoflavone | - | - | - | [2] 96 96, 97 💬
|
| 1433 | Terbinafine | [1] Terbinafine Terbinafine | [2] Terbinafine hydrochloride
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | [3] 96 96, 97, 271 💬
|
| 1434 | Tetomilast | [1] Tetomilast Tetomilast | - | - | - | [2] 96 96, 97 💬
|
| 1435 | TEV-48574 | - | - | - | - | [2] 96 96, 97 💬
|
| 1436 | TEV-48574 Dose Regimen A | - | - | - | - | [2] 96 96, 97 💬
|
| 1437 | TEV-48574 Dose Regiment B | - | - | - | - | [2] 96 96, 97 💬
|
| 1438 | TEV-48574Product Code: TEV-48574Pharmaceutical Form: Solution for injectionINN or Proposed INN: TEV-48574Current Sponsor code: TEV-48574Other descriptive name: Fully human IgG1 monoclonal antibody specific for TL1AConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150- | - | - | - | - | [2] 96 96, 97 💬
|
| 1439 | TH-SC01 | - | - | - | - | [1] 96 96 💬
|
| 1440 | Thalidomide | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 2 2, 16, 20, 28, 49, 51, 53, 56, 63, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
|
| 1441 | THALIDOMIDE CELGENE - 50 MG CAPSULA RIGIDA - USO ORALE - BLISTER (PVC/PE/ACLAR/ALU) 28 CAPSULE | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1442 | Thalidomide Pharmion | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 85 85, 96, 97 💬
|
| 1443 | THC 5mg/ml and CBS 50mg/ml | - | - | - | - | [1] 96 96 💬
|
| 1444 | The IMP is authorized but for a different indication and route of administration. IMP will be budesonide in nebulized suspension but for oral administration. The idea is local action, low dose available in this formula and very low bioavailability. | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1445 | The investigational medicinal product (IMP) may be labelled as either PF-04236921 106 mg/vial, Clonal SC lyophilized form” or PF-04236921 Powder for Injection, 106 mg/vial”. Supplies labelled with either nomenclature are equivalent. | - | - | - | - | [1] 96 96 💬
|
| 1446 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA | - | - | - | - | [1] 96 96 💬
|
| 1447 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA. | - | - | - | - | [1] 96 96 💬
|
| 1448 | Thetanix | - | - | - | - | [1] 96 96 💬
|
| 1449 | Thiopurine | - | - | - | - | [2] 96 96, 97 💬
|
| 1450 | Thiosix | - | - | - | - | [2] 96 96, 97 💬
|
| 1451 | Thiotepa | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [14] 13 13, 19, 20, 28, 46, 51, 60, 65, 85, 96, 107, 164, 284, 285 💬
|
| 1452 | Threonine | [1] Threonine Threonine | [1] Threonine
Threonine
💬
| - | - | [3] 86 86, 96, 97 💬
|
| 1453 | THRX-139060 | - | - | - | - | [2] 96 96, 97 💬
|
| 1454 | Thymoglobulin | - | - | - | - | [6] 34 34, 36, 51, 60, 96, 118 💬
|
| 1455 | THYMOGLOBULINE | - | - | - | - | [5] 13 13, 36, 51, 60, 96 💬
|
| 1456 | Ticilimumab | - | - | - | - | [1] 96 96 💬
|
| 1457 | Time and attention | - | - | - | - | [2] 96 96, 97 💬
|
| 1458 | Time and attention + active fructooligosaccharide supplementation | - | - | - | - | [2] 96 96, 97 💬
|
| 1459 | Tirzepatide | [1] Tirzepatide Tirzepatide | [1] Tirzepatide
Tirzepatide
💬
| [2] GIPR GIPR, GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [6] 67 67, 96, 97, 193, 233, 265 💬
|
| 1460 | TNF inhibitors | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1461 | TNF kinoid | - | - | - | - | [2] 46 46, 96 💬
|
| 1462 | TNF-alpha antagonists | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 1463 | TNF-K | - | - | - | - | [2] 46 46, 96 💬
|
| 1464 | TNF-Kinoid | - | - | - | - | [2] 46 46, 96 💬
|
| 1465 | TNFa Antagonist - Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1466 | TNFa Antagonist - Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1467 | TNFa Kinoid | - | - | - | - | [2] 46 46, 96 💬
|
| 1468 | TNFa-Kinoid | - | - | - | - | [1] 96 96 💬
|
| 1469 | To be determined | - | - | - | - | [2] 96 96, 113 💬
|
| 1470 | To be requested | - | - | - | - | [2] 96 96, 97 💬
|
| 1471 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 1472 | Tofacitinib (CP-690,550) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 96 96 💬
|
| 1473 | Tolerogenic dendritic cells | - | - | - | - | [2] 46 46, 96 💬
|
| 1474 | Top down treatment if patient at high risk | - | - | - | - | [2] 96 96, 97 💬
|
| 1475 | Top-down | - | - | - | - | [1] 96 96 💬
|
| 1476 | TR004 (Treg immunotherapy) | - | - | - | - | [2] 96 96, 97 💬
|
| 1477 | Transfusion | - | - | - | - | [1] 96 96 💬
|
| 1478 | Treatment according to current standards without knowledge of serum infliximab and anti-infliximab Ab status | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1479 | Treatment with Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1480 | Triamcinolone | [1] Triamcinolone Triamcinolone | [4] Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [11] 35 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 💬
|
| 1481 | Trichuris suis eggs | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 1482 | Trichuris suis Ova | - | - | - | - | [4] 13 13, 46, 96, 97 💬
|
| 1483 | Trichuris suis ova (TSO) | - | - | - | - | [2] 96 96, 97 💬
|
| 1484 | Trichuris trichiura eggs | - | - | - | - | [1] 96 96 💬
|
| 1485 | Trilac | - | - | - | - | [2] 96 96, 97 💬
|
| 1486 | Tripterygium glycosides | - | - | - | - | [1] 96 96 💬
|
| 1487 | TRK-170 | - | - | - | - | [1] 96 96 💬
|
| 1488 | Trosunilimab | - | - | - | - | [1] 96 96 💬
|
| 1489 | TRX103 | - | - | - | - | [1] 96 96 💬
|
| 1490 | Trypsin | [1] Trypsin Trypsin | [1] Trypsin, crystallized
Trypsin, crystallized
💬
| - | - | [1] 96 96 💬
|
| 1491 | TSO 250 | - | - | - | - | [1] 96 96 💬
|
| 1492 | TSO 2500 | - | - | - | - | [1] 96 96 💬
|
| 1493 | TSO 7500 | - | - | - | - | [1] 96 96 💬
|
| 1494 | TU-100 | [1] TU-100 TU-100 | - | - | - | [1] 96 96 💬
|
| 1495 | Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [5] 46 46, 51, 96, 97, 271 💬
|
| 1496 | TV-5600 | - | - | - | - | [3] 8 8, 13, 96 💬
|
| 1497 | Ultrasound Elastography | - | - | - | - | [1] 96 96 💬
|
| 1498 | Ultrasound Imaging | - | - | - | - | [2] 34 34, 96 💬
|
| 1499 | Ultrasound Microbubble Contrast Agent | - | - | - | - | [1] 96 96 💬
|
| 1500 | Ultrasound Vascularity | - | - | - | - | [1] 96 96 💬
|
| 1501 | Undetermined | - | - | - | - | [2] 96 96, 97 💬
|
| 1502 | Upadacitinib | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [12] 40 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
|
| 1503 | Upadaticitib | - | - | - | - | [1] 96 96 💬
|
| 1504 | Ursodeoxycholic acid | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [10] 6 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
|
| 1505 | Ursofalk | - | - | - | - | [4] 93 93, 94, 96, 97 💬
|
| 1506 | UrsoFalk® 250 mg tabletten. | - | - | - | - | [1] 96 96 💬
|
| 1507 | US TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] Epinephrine
Epinephrine
,
Epinephrine hydrochloride
,
Bupivacaine hydrochloride
,
Epinephrine bitartrate
,
Bupivacaine
💬
| [15] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1508 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
| 1509 | Ustekinumab (6 mg/kg) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1510 | Ustekinumab (90 mg) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1511 | Ustekinumab (approximately 6 mg/kg) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 49 49, 96 💬
|
| 1512 | Ustekinumab (UST) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1513 | Ustekinumab - Standard Dosage | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1514 | Ustekinumab 130 mg IV | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1515 | Ustekinumab 1mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1516 | Ustekinumab 3 mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1517 | Ustekinumab 4.5 mg/kg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1518 | Ustekinumab 45 mg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 93 93, 96 💬
|
| 1519 | Ustekinumab 6 mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1520 | Ustekinumab 90 mg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 50, 56, 93, 96, 97 💬
|
| 1521 | Ustekinumab 90 mg (SC) Group 1 | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1522 | Ustekinumab 90 mg (SC) Group 2 | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1523 | Ustekinumab 90 mg SC q12w | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1524 | Ustekinumab 90 mg SC q8w | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1525 | Ustekinumab and semi enteral nutrition | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1526 | Ustekinumab and Upadacitinib | [2] Upadacitinib Upadacitinib, Ustekinumab | [4] Ustekinumab
Ustekinumab
,
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [4] IL12A IL12A, IL12B, IL23A, JAK1 💬
| [43] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis 💬 | [1] 96 96 💬
|
| 1527 | Ustekinumab approximately 6 mg/kg (IV) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1528 | Ustekinumab Injection [Stelara] | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1529 | Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1530 | Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1531 | Ustekinumab IV Infusion | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1532 | Ustekinumab SC Injection | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1533 | Usual current care | - | - | - | - | [2] 96 96, 97 💬
|
| 1534 | UTTR1147A | - | - | - | - | [2] 96 96, 97 💬
|
| 1535 | UTTR1147A, IL22-Fc, IL-22Fc | [1] Efmarodocokin alfa Efmarodocokin alfa | [1] Efmarodocokin alfa
Efmarodocokin alfa
💬
| [1] IL22 IL22 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 1536 | UTTR1147A/RO7021610 (Active) | - | - | - | - | [2] 96 96, 97 💬
|
| 1537 | UVADEX | - | - | - | - | [3] 46 46, 51, 96 💬
|
| 1538 | UVADEX and UVAR XTS Photopheresis System | - | - | - | - | [1] 96 96 💬
|
| 1539 | V565 | - | - | - | - | [2] 96 96, 97 💬
|
| 1540 | Vancomycin | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [9] 6 6, 13, 46, 70, 94, 96, 97, 296, 299 💬
|
| 1541 | Vancomycin /Amphotericin B (Fungizone®) /Gentamicine 80 mg | [2] Amphotericin B Amphotericin B, Vancomycin | [3] Amphotericin B
Amphotericin B
,
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [2] 96 96, 97 💬
|
| 1542 | VEDOLIZUMAB | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3] 94 94, 96, 97 💬
|
| 1543 | Vedolizumab (Genetical Recombination) | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1544 | Vedolizumab (VDZ) | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1545 | Vedolizumab 300 MG Injection [Entyvio] | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1546 | Vedolizumab intravenous injection | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1547 | Vedolizumab IV | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3] 94 94, 96, 97 💬
|
| 1548 | Vedolizumab IV (Entyvio¿) | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1549 | Vedolizumab IV (Entyvio™) | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1550 | Vedolizumab IV 300 mg | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1551 | Vedolizumab SC | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1552 | Vedolizumab SC 108 mg | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1553 | Vedolizumab subcutaneous injection | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1554 | Vedolizumab, Entyvio | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1555 | Vehice Control | - | - | - | - | [1] 96 96 💬
|
| 1556 | Venous blood samples, anal swab samples, vaginal swab samples, high resolution anoscopy (HRA), anal biopsy samples | - | - | - | - | [2] 96 96, 97 💬
|
| 1557 | Verapamil | [1] Verapamil Verapamil | [2] Verapamil hydrochloride
Verapamil hydrochloride
,
Verapamil
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 57 57, 58, 96, 140, 167 💬
|
| 1558 | VIAGRA | - | - | - | - | [3] 86 86, 96, 225 💬
|
| 1559 | VIALEBEX | - | - | - | - | [1] 96 96 💬
|
| 1560 | Vialebex 200mg | - | - | - | - | [1] 96 96 💬
|
| 1561 | Vidofludimus | [1] Vidofludimus Vidofludimus | [2] Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [5] 13 13, 46, 94, 96, 97 💬
|
| 1562 | VIDOFLUDIMUS CALCIUM | [2] Calcium Calcium, Vidofludimus | [2] Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [4] 13 13, 94, 96, 97 💬
|
| 1563 | Vigantol Oel | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 1564 | Vigantol Oel TM | - | - | - | - | [2] 96 96, 97 💬
|
| 1565 | Visilizumab | [1] Visilizumab Visilizumab | [1] Visilizumab
Visilizumab
💬
| [3] CD3D CD3D, CD3E, CD3G 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 1566 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [26] 3 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
|
| 1567 | Vitamin D (Cholecalciferol ) | [2] Cholecalciferol Cholecalciferol, Vitamin D | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1568 | Vitamin D drops | [1] Vitamin D Vitamin D | - | - | - | [2] 96 96, 97 💬
|
| 1569 | Vitamin D3 | - | - | - | - | [12] 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
|
| 1570 | Vitamin D3 (Cholecalciferol) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1571 | Vitamin D3 3000 UI daily | - | - | - | - | [1] 96 96 💬
|
| 1572 | Vitamin D3 4000 UI daily | - | - | - | - | [1] 96 96 💬
|
| 1573 | Vitamin D3 800 UI/day then 800 UI/day | - | - | - | - | [1] 96 96 💬
|
| 1574 | Vitamin D3: 3000 or 4000 UI/day then 2,000 UI/day | - | - | - | - | [1] 96 96 💬
|
| 1575 | Vitamin E | [1] Vitamin E Vitamin E | [1] Vitamin E
Vitamin E
💬
| - | - | [12] 2 2, 6, 13, 19, 20, 46, 90, 96, 97, 206, 299, 317 💬
|
| 1576 | Vitamin E 800IU | [1] Vitamin E Vitamin E | [1] Vitamin E
Vitamin E
💬
| - | - | [2] 96 96, 97 💬
|
| 1577 | Vitamin K 10 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 1578 | Vorinostat | [1] Vorinostat Vorinostat | [1] Vorinostat
Vorinostat
💬
| [11] HDAC1 HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬
| [20] ATP-dependent chromatin remodeling ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | [5] 65 65, 75, 96, 97, 156 💬
|
| 1579 | VSL#3 | - | - | - | - | [4] 96 96, 97, 107, 291 💬
|
| 1580 | VSL#3 (Original De Simone formulation) | - | - | - | - | [2] 96 96, 97 💬
|
| 1581 | VSL#3® | - | - | - | - | [2] 96 96, 97 💬
|
| 1582 | VTX-958 | - | - | - | - | [1] 96 96 💬
|
| 1583 | VTX958 | - | - | - | - | [1] 96 96 💬
|
| 1584 | Warfarin | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [15] 6 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
|
| 1585 | Warfarin 10 mg | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [2] 96 96, 97 💬
|
| 1586 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 1587 | Wellbutrin (bupropion) | [1] Bupropion Bupropion | [3] Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 96 96 💬
|
| 1588 | WFI | - | - | - | - | [1] 96 96 💬
|
| 1589 | Whey | [1] Whey Whey | - | - | - | [4] 6 6, 46, 96, 97 💬
|
| 1590 | Whey protein | [1] Whey Whey | - | - | - | [2] 6 6, 96 💬
|
| 1591 | Whole body Protein turnover | - | - | - | - | [4] 19 19, 46, 96, 299 💬
|
| 1592 | WMT | - | - | - | - | [1] 96 96 💬
|
| 1593 | Xanthohumol | [1] Xanthohumol Xanthohumol | - | - | - | [1] 96 96 💬
|
| 1594 | Zasocitinib | [1] Zasocitinib Zasocitinib | [1] Zasocitinib
Zasocitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [2] 96 96, 97 💬
|
| 1595 | Zessly | - | - | - | - | [2] 96 96, 97 💬
|
| 1596 | Zoledronic acid | [1] Zoledronic acid Zoledronic acid | [5] Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [16] 5 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬
|
| 1597 | ZP1848 | - | - | - | - | [1] 96 96 💬
|
| 1598 | ÁCIDO GADOBÉNICO | - | - | - | - | [1] 96 96 💬
|